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The detection and quantification of cardiac biomarkers in serum is crucial to 
diagnose patients in the early stage of a disease. The recent advances in microfluidics 
technology can improve diagnostics by reducing the application time and integrating 
several clinical analysis into a single, portable device called lab-on-a-chip (LOC). The 
development of such immunosensing LOC is a major thrust of the rapidly growing 
bionanotechnology industry. It involves a multidisciplinary research effort encompassing 
microfluidics, microelectronics and biochemistry. This thesis work focused on the 
development of immunoassays on microfabricated gold inter-digitated transducers (IDT) 
on silica and glass substrates. The concept of label-free, affinity-based biosensing is 
introduced with a special emphasis to impedance spectroscopy. Different protocols 
involving the covalent immobilization of cancer risk marker (human epidermal growth 
factor, hEGFR) and cardiac risk marker proteins C reactive protein (CRP), interleukin (IL-
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6) and nicotinamide phosphoribosyltransferase (Nampt) single stranded deoxyribonucleic 
acid were investigated. For this, IDTs were fabricated using integrated circuit (IC) 
fabrication processes providing compatibility for the integration of electronic circuits, for 
single-chip and lab-on-a-chip biosensing applications.  
 
The thesis also involves development of a poly dimethylsiloxane (PDMS)-based 
fluidic system comprising on-chip actuated mechanism for multi-target immunosensing 
applications. The fluidic flow is controlled by an applied hydraulic pressure on the 
micropump. Label-free affinity type sensing was carried out using two different biological 
recognition elements (a) immunosensing approach using antibodies for hEGFR and IL-6 
was employed and the function of the LOC was analyzed for detection of hEGFR and IL-6 
as model analytes. A detection limit of 0.1ng/ml of hEGFR and IL-6 in serum was obtained 
without any signal amplification. (b) label-free affinity-based methodology using ssDNA 
aptamers specific for Nampt to develop an aptasensor and obtained a detection limit of 1 
ng/ml in serum for Nampt, which is the most sensitive detection range with the application 
of the aptamer for Nampt.  
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Kan serumundaki kardiyak ve kanser biyo-işaretlerinin algılanması ve miktarlarının 
ölçülmesi hastalara erken tanı konulması için hayati önem taşımaktadır. Mikroakışkan 
teknolojisindeki en son gelişmeler, uygulama zamanını düşürerek ve birbirinden farklı 
klinik analizleri yonga üstü laboratuvar (LOC) olarak adlandırılan taşınabilir tek bir aygıt 
üzerinde birleştirerek hastalıkların teşhis edilmesini kolaylaştırabilir. Böyle bir yonga üstü 
laboratuvarın geliştirilmesi,  hızla gelişen biyoteknoloji endüstrisisin bir ihtiyacı olup 
mikro akışkan, mikro elektronik ve biyokimya alanlarını kapsayan çok disiplinli bir 
araştırma gerektirmektedir.Bu tezdeki çalışmalar silikon ve cam tabanda üretilen altın 
interdigitated transdüserlerin (IDT) üstünde immünoeseylerin geliştirilmesi üzerine 
odaklanmıştır. Etiketsiz, afinite-temelli biyoalgılama konsepti empedans spektroskopisine 
özel önem verilerek sunulmaktadır. Anti-CRP, hEGFR, IL-6, aptamer ve Nampt ssDNA 
gibi risk teşkil eden proteinlerin kovalent bağlanmasıyla ilgili degişik protokoller 
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incelenmiştir. Bunun için IDT’ler yonga üstü biyoalgılama uygulamaları için elektronik 
devrelerin entegre edilmesine uyum sağlayan, entegre devre üretim yöntemleriyle 
üretilmişlerdir. 
 
Bu tez ayrıca çoklu hedef immunosensing uygulamaları için yonga üstü mekanizma 
ile uyarılan PDMS-temelli bir LOC geliştirilmesini de içermektedir. Akışkan akışı bir 
mikro pompa üzerine uygulanan hidrolik basınç ile kontrol edilmektedir. Etiketsiz afinite 
tipi algılama iki farklı biyolojik tanımlama elementi kullanılarak yapılmıştır (a) hEGFR  ve 
IL-6 için antikor kullanan immunosensing yöntemi kullanıldı ve  LOC’un anti-hEGFR ve 
IL-6’i analitlerini algılamadaki işlevselliği analiz edilmiştir. Hiçbir sinyal güçlendirmesi 
olmaksızın, kandaki hEGFR ve IL-6 için algılama limiti 0.1ng/ml olarak elde edildi. (b) 
Aptasensör geliştirmek için Nampt için spesifik ssDNA aptamerleri kullanarak etiketsiz 
afinite temelli metodolojisi  kullanıldı ve Nampt için 1ng/ml algılama limiti elde edildi. Bu 
Nampt için aptamer uygulanması ile elde edilen en hassas algılama aralığıdır. 
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Chapter I 
1. INTRODUCTION 
1.1 Motivation for Cardiac Biomarker Detection and Background Information 
Millions of patients around the world are at risk of mortality from preventable 
diseases like cardiovascular events and cancers. Recent reports by world health 
organization (WHO) on cardiovascular diseases (CVDs) stated that these diseases 
constitute one of the major cause of death in worldwide [1-5]. An estimated 17.1 million 
people die each year that represents 30% of all global deaths. Of these deaths, an estimated 
7.6 million were due to coronary heart disease and 5.7 million were due to stroke. Over 
80% of CVD deaths take place in low- and middle-income countries and occur almost 
equally in men and women. By 2015, almost 20 million people may die because of heart 
disease and stroke. These are assumed to remain the major causes of death and some 
cancer types[6] follow them. Lack of knowledge about the disease inflammation stage 
could be the main reason why less than 10 % of the effected population is being treated. 
There are different kinds of markers in human body which are the fundamental 
indicators in the diagnosis of many CVD [7] and cancer [8] diseases. The levels of the 
markers change in disease conditions. Table 1-1 summarizes the list of CVD and cancer 
markers with respective concentrations of normal and disease levels. Moreover, some 
markers such as interleukin-6, C-reactive protein and nicotinamide 
phosphoribosyltransferase may represent more than one disease. The increase in the 
specific marker levels above the normal level is the primary indication for a risk. 
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Table 1-1: Summary of CVD and cancer markers with their disease levels. 
Protein Marker Type of Disease  Normal 
levels 
Disease 
levels 
Reference 
Interleukin-1β (IL-1) Cardiovascular 
risk 
<70.0 pg/ml 120 pg/ml Pearson et al. (2003) 
Circulation 107, 499-
511. 
Interleukin-6 (IL-6) Cardiovascular 
risk (♥); Cancer 
risk 
4.0 pg/ml 138 pg/ml (♥) Manukyan et al. 
(2008) Clin. 
Biochem. 41, 920-
922. 
Tissue necrosis factor 
(TNFα) 
Cardiovascular 
risk 
4.8 pg/ml 48 pg/ml Manukyan et al. 
(2008) Clin. 
Biochem. 41, 920-
922. 
Intercellular adhesion 
molecule-1 (ICAM-1) 
Cardiovascular 
risk 
227 ng/ml 513 ng/ml Secor et al. (1994) 
Infection and 
Immunity, 62, 2695-
2701. 
Selectin Cardiovascular 
risk 
32 ng/ml 53 ng/ml Secor et al. (1994) 
Infection and 
Immunity, 62, 2695-
2701. 
Fibrinogen Cardiovascular 
risk 
2.5 g/l 5.6 g/l Brown et al. (2005) 
Journal of American 
Medical Association 
(JAMA) 294, 1799-
1809. 
Serum amyloid A 
(SAA) 
Cardiovascular 
risk 
3.7 mg/l 2200 mg/l Wilkins et al. 
ClinChem (1994) 40, 
1284-1290 
C-reactive protein 
(CRP) 
Cardiovascular 
risk (♥); Cancer 
risk 
0.22mg/dl > 1 mg/dl (♥) Manukyan et al. 
(2008) Clin. 
Biochem. 41, 920-
922. 
Epidermal growth 
factor receptor 
(EGFR) 
Cancer risk <8 ng/ml > 8 ng/ml Rubin et al. (1998) 
JNCI J Natl Cancer 
Inst. 90(11), 824-
832. 
Nicotinamide 
phosphoribosyltransfe
rase(Nampt) 
Diabetes (О); 
Cardiovascular 
risk; Cancer risk 
15.8 ng/ml 31.9 ng/ml 
(О) 
M.P. Chen et al. 
(2006)  J Clin. 
Endocrinology and 
Metabolism, 91, 295-
299. 
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1.2 Currently available Products in Market for the Diagnosis 
The market comprises two types of participants including companies developing 
biosensor-based devices and developers of biosensor technology. Key players engaged in 
developing biosensor technology include Aga Matrix Inc., Cranfield Biotechnology 
Center, Life Sensors Inc., M-Biotech, and Nova Biomedical. Leading manufacturers of 
biosensor-based devices include - Abbott Point Of Care Inc., Affinity Sensors, Neosensors 
Limited, Siemens Healthcare Diagnostics Inc, Animas Corporation, Life Scan Inc., 
Medtronic Diabetes, and Roche Diagnostics Ltd. Most players in the above list are catering 
the diagnostic, prognostic needs of diabetic patients all over the world. Their products and 
functions are provided in Table 1-2. To our knowledge, only Abott and Siemens health 
care produce diagnostic device/cartridge for single CVD marker.  
Table 1-2: Summary about products and their functions. 
 
Company Product Information Function
Aga Matrix Inc. Key Note, KeyNote pro, Jazz, 
Presto
Blood Glucose Monitoring Systems
Lifesensors Inc.  SUMO pro, SUMO-3, SUMO 
star
Protein expression systems for 
bacteria`s
M-Biotech Alarm Monitoring system Blood Glucose Monitoring Systems
Nova Biomedical MRI coils for scanning purposes
Abott point of care Inc. I STAT 1, catridges for blood 
gas, chemistry, coagulation and 
cardiac markers
Testing for Blood Gases, Electrolytes, 
Chemistries, Coagulation, 
Hematology, Glucose, and Cardiac 
Markers (cTnI)
Siemens Healthcare 
Diagnostics Inc. 
Stratus® CS Acute Care™ 
Diagnostic System - Features & 
Benefits
Provides quantitative cardiac assays 
for fast, cost-effective evaluation of 
patients presenting with suspected 
myocardial ischemia.
Animas Corp. One touch ping Blood Glucose Monitoring Systems
Life Scan Inc. One Touch Ultra series Blood Glucose Monitoring Systems
Medtronic Diabetes Mini med paradigm REAL-Time Insulin Pump and 
Continuous Glucose Monitoring 
System
Roche Diagnostic Ltd. Acuchek, Cobas, Coasay, 
Confirm 
In-vitro diagnostics
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The major disadvantages of the currently available products are the cost and the 
inability to quantify multiple markers on a single cartridge. For example, troponin I 
(cardiac marker) detecting cartridge from Abott point of care inc. costs $650 [9-10] which 
is expensive for a single marker, and the expenses will enhance to detect multiple disease 
markers. Thus, there is a need for alternate, cost effective diagnostic device for multiple 
marker detection and quantification.  
1.3 The Need for Multiple Marker Quantification 
It is often difficult to distinguish those individuals with a moderate baseline risk who 
might benefit from aggressive risk reduction strategies from the levels of a single protein 
marker. For example, the inflammation of CVD is illustrated in Figure 1-1. Initially, the 
pro-inflammatory risk markers (proteins) such as interleukin-1, tissue necrosis factor alpha, 
and interleukin-6 are dominant during the early stages of CVD.  As disease progresses to 
acute stage, the marker proteins, such as myoglobin, serum amyloid A and C-reactive 
protein are more active. It has been observed that the majority of the deaths occur after the 
acute stage [11]. Therefore, additional tests are applied for the prediction of risk in disease 
individuals may be needed and will enhance the individual’s diagnostic expenses. The 
parallel analysis of multiple markers with a single test using small volumes of serum 
sample greatly enhances the applicability of device in disease stage quantification with 
minimized diagnostic expenses. Thus, potential candidates can be verified at the early 
stage of disease.  
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• Interleukin-1  (IL-1)
• Tissue Necrosis Factor α (TNFα)
• Interleukin-6 (IL-6)
STAGE-1 
(Early diagnosis)
Pro-inflammatory 
risk factors 
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molecules
• Intercellular adhesion molecule-1 (ICAM1)
• Selectins
• Myoglobin
• Serum amyloid A (SAA)
• C-reactive protein (CRP)
STAGE-3 
(Acute stage)
Acute phase 
reactants
Disease progression 
Ti
m
e
Inflammation of cardiovascular disease
 
Figure 1-1: Cardiovascular disease progression from pro-inflammatory to acute stage over 
time[11]. 
1.4 Immunoanalysis 
The key element in any immuno-based technique is the applied antibody (Ab) made 
of globular proteins, produced by the immune system of the mammals as a defense against 
foreign agents (antigen, Ag). Among the various immunochemical techniques [12], 
immunoassays are more versatile and can be manipulated as various formats for particular 
purposes ranging from quantitative laboratory tests [13-14] to simple “yes/no” screening 
tests [15-16]. These advantages can be exploited in monitoring programs where great 
number of samples needs to be analyzed.  
Currently, laboratory-oriented affinity-based methods/sensing mechanisms are being 
used for the detection and quantification of multiple-marker content of serum. These 
include the enzyme-linked immunosorbent assay (ELISA) [17], radio immunosorbent 
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assay (RIA) [18] and flouroscence immunosorbent assay (FIA) [19]. These methods are 
derived from the immunoassay technology, where signal detection is facilitated by the use 
of enzyme/flouropore labels [20]. These methods have several limitations including the 
requirement for complex reagents, qualifying the presence of the target molecules/analytes 
only, generation of radioactive residues in RIA, fluorescent-labeling as in sandwich-type 
arrays when applied to biological fluids limit the sensitivity due to background noise and 
the necessity for heavy/expensive instrumentation [21]. Therefore, there is a clear need for 
a clean and rapid method to quantify the levels of multiple proteins in serum to determine 
potential disease candidates that may benefit from therapeutic interventions in the early 
stages of diseases.  
1.5 Label-free, Affinity-based Immunosensor 
Alternatively, immunoassay technologies provide label-free mechanisms based on 
the change of surface properties upon protein-target binding. Label-free affinity-type 
biosensors are fast, inexpensive and do not require the use of detection labels (fluorescent, 
radio or colorimetric) to facilitate measurements. Besides the time and expense benefits of 
omitting the labeling step, label-free operation enables detection of target-probe binding in 
real time [22], which is generally not possible with label-based systems. Real-time sensing 
confesses at least two major advantages over endpoint detection. First, time averaging of 
binding/unbinding events can improve measurement accuracy. Second, it allows 
determination of affinity constants by curve-fitting the sensor output vs. time [23]. For 
accurate results, effects including diffusion rate and steric hinderance must be accounted 
for, just as in surface plasmon resonance (SPR) [24]. Furthermore, it is important to know 
the relationship between the amount of bound target and sensor output as signal. 
 
Interdigitated electrodes have been widely used and are still being explored by many 
investigators for the development of label-free affinity-based sensing mechanisms [25-32]. 
The capacitance between the interdigitated electrodes can be described by the basic 
capacitance equation (1.1). 
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d
AC orεε=      (1.1) 
where εr is the relative dielectric constant, A is the electrode area, and d is the pitch 
between two consecutive electrodes. When there is any change in the dielectric properties 
of the material between the electrodes, a change in the capacitance will occur and it is 
correlated to the bound target captured by the immobilized protein molecules on the 
surface. The non-specific signal can be minimized simply by washing away the unbound 
species on the sensor surface [33]. 
 
Thus, by using label-free sensors, detailed information on an interaction can be 
obtained during the analysis while minimizing sample processing requirements and assay 
run times. However, this technique has limitations due to technical and experimental 
constraints, such as portability, control of sensor surface, high user expertise requirements. 
With the recent advances in microfluidic technology, these constrains can be surpassed by 
developing a device for the rapid measurement of protein levels in serum in small volumes. 
1.6 Microfluidic Technology 
The advent of micro-fabrication technologies plays a significant role for the 
development of fluid-based devices at microscopic length scales. The introduction of novel 
concept of chemical sensing was investigated by Manz et al. [34], provoked many 
researchers for the development of microfluidic technologies in the application areas of 
chemistry and life sciences, where several complex laboratory functions such as pre-
treatment, analyte sample separation, bio-chemical reaction, label/label-free detection, and 
fluid handling were integrated onto a single chip and it can be referred as lab-on-a-chip 
(LOC) [35-36]. The dexterity of LOC delivers numerous advantages such as low 
consumption of reagents, integration to multiple processes, lower analysis time and higher 
sensitivity and the reliability. Thus, LOC technologies are widely used in the applications 
of drug discovery [37-39], controlled drug delivery [40-41], single/multiple cell analysis 
[42-44], genome analysis [45-47], proteomics [48-49] and portable point-of-care systems 
[50-52].  
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Current focus in developing microfluidics research can be broadly categorized as: 
i. Application driven development of devices (LOC), 
ii. Realization of new fluid transfer/control mechanism,  
iii. Development of new, reliable and economical fabrication technology for these 
devices. 
Among the various applications of LOC, the immunoanalysis for the detection of 
disease markers using LOC technology with on-chip actuated mechanism is not explored 
to the extent. 
 
The precise and low cost fluid control is hard to achieve without the integration of 
on-chip fluidic components to the off-chip control systems. Thus, until recently, the precise 
fluid control can only be achieved by the expensive and complex methods such as 
externally controlled electro-kinetic flows and active components (micropumps and micro-
valves). Several groups developed the off-chip actuating mechanisms with the combination 
of electro-hydrodynamic [53-55], electro-osmotic [56-57], electrostatic [58-59], 
electromagnetic [60-61], magneto-hydrodynamic [62-63], piezoelectric [64-66], 
thermopneumatic[67-69], and pneumatic [70-71] actuation principles through the actuating 
sources/micropumps. Thus, an astonishing diversity is achieved on the micropump 
concepts and devices as a result of wide spread research activities on micropumps, 
reaching from peristaltic pumps to a large number of micro diaphragm pumps to the high-
pressure devices without any moving parts. However, no recognizable work has been 
performed for the integration of biosensor platform to an on-chip actuated fluidic system. 
 
Recently, alternate strategies have been extensively studied to develop on-chip 
actuating mechanisms with no external instrumentation. For example, Park et al. [72], have 
developed an electrochemical immunosensing disposable LOC integrated with latch 
mechanism for hand operation for the detection of glucose (Figure 1-2). Hydraulic pressure 
(pressing with the finger) is applied on the inlet section (reservoir cum actuator) to sprout 
liquid into the reaction chamber. The methodology has severe drawbacks to be modified 
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for point-of-care and hand-held applications. Firstly, the complexity in multilayered 
fabrication and the bonding between the glass and first PDMS layer is not permanent, 
hence the liquid leak during the latch operation is inevitable. Moreover, the design is 
limited for label-free single target detection. Secondly, the signal transducing method, the 
faradic measurement where same working electrode on the LOC was used without 
considering the unavoidable electrode fouling effects. The setup to measure the transducer 
signal and use of micro syringes for loading analytes hinders its real time application. 
 
In another work, Moorthy et al. [73] have performed a calorimetric, disposable 
botolinium toxin enzyme-linked immunosorbent assay (ELISA) with an integrated micro-
fluidic device.  However, the inept approach to sprout liquid from multiple reservoirs using 
multiple integrated micro-pumps and lack of proper air-vent to avoid the backward flows 
impedes its objective in hand-held applications. 
 
 
Figure 1-2: Current immunosensing LOC in research[72]. Disadvantages: complex 
fabrication procedure, transduction principle and single target detection. 
10 
 
1.7 Aims and Scope of Work 
Miniaturization of analytical systems [74] proved to be advantageous with regard to 
reduction of the sample volumes and required reagents as well, allowing medical diagnosis 
from as low as a drop of blood. Moreover, analysis times are usually shorter and several 
assays can be integrated in a single system without extending the size and complexity of 
the device. The aim of this research however also includes development of a multi-target 
immunosensing LOC, which is integrated with an on-chip actuating micropump for 
propelling the working fluids. One of the primary scopes of this thesis includes the 
realization of an integrated hand-operating micropump using microfluidic technology, 
development of stable label-free immunoassay for multiple targets and testing the LOC 
with label-free immunoassay.  
 
The development of such systems is not just transfer of an analytical assay to a 
microsystem. The following challenges of this work to be considered in realizing a viable 
microfluidic LOC: 
i. The reduction of dimensions also reduces volumes which are accessible to the 
transducer and may degrade the signal. Thus, effective and sensitive transducing 
mechanisms to be implemented. 
ii. Manipulating a surface for compatibility with conjugation of more than one protein 
marker, while retaining protein recognition properties. 
iii. Compatible and economical fabrication technologies to be adopted without 
perturbing the protein analytical properties.  
iv. The application of capillaries increases the flow resistance for pressurized flow of 
liquid. At present the most important mechanism used to control liquid flow is 
electro-kinetics which requires no additional components such as pumps or valves, 
but the integration of electrodes usually platinum/gold and the application of 
electric fields are needed. Thus, alternative methods such as on-chip actuation 
pumps for liquid transportation were to be integrated. 
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Moreover, attempts are made to quantify proteins using specific aptamers by label-
free methodology and to investigate nickel as alternate transducing electrode material for 
laboratory-based applications. The selection of protein markers is not the main objective of 
this work, therefore, further guidance and support is to be received to complete these tasks 
of the thesis. 
1.8 Organization of Thesis 
This thesis contains seven chapters that explain fabrication of IDTs, development of 
microfluidic systems, integration of fabricated IDTs with fluidic system for 
immunosensing, label-free aptasensing, alternate transducing electrode materials and 
finally conclusions. A brief outline of each of the chapters is given below. 
i. Chapter 2 contains the behavior and characteristics of the IDT at high 
frequencies which was performed using ADS: MOMENTUM. The final 
section presents the comparison of the simulation results to the experimental 
test results of fabricated structures 
ii. The design and fabrication of a portable PDMS-based microfluidic system with 
on-chip actuated mechanism was discussed in Chapter 3. 
iii. Chapter 4 presents the validation of the fluidic system as an immunosensing 
LOC in which epidermal growth factor (EGFR) and interleukin (IL-6) 
antibodies were used as model analytes. 
iv. Chapter 5 details the application of label-free sensing approach using Nampt 
specific ssDNA aptamer. The target levels were quantified in buffer as well as 
serum (1-250 ng/ml). 
v. Chapter 6 contains the investigation on alternate transducing electrode for 
immunoassay applications. 
vi. Chapter 7 elaborates on the efforts towards the physical realization of the 
immunosensing LOC and summarizes the achievements of this research which 
is followed by conclusions and suggestions for future work.  
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Chapter II 
2. STRUCTURAL MODELIING AND FABRICATION OF TRANSDUCERS 
Interdigitated capacitor (IDC) or interdigitated transducers (IDT) have been studied 
by many groups since the early 1970s. The applications for these structures include their 
use in lumped elements for microwave integrated circuits [75-76], optical and surface 
acoustic wave devices [77], optically controlled microwave devices [78], thin-film 
acoustic–electronic transducers and tunable devices [79], dielectric studies on thin films 
[80]. More recently, studies had been made with IDC/IDT for humidity [81-82] and 
chemical sensors [83-86]. Typical IDT sensors (IDTs) are made of an ‘inert’ substrate over 
which the two comb electrodes are deposited. One biological/chemical sensitive layer is 
then deposited over the electrodes. The sensitive layer can be chosen according to its 
affinity to a particular molecule or set of molecules one wishes to detect. If several sensors 
with different sensitive layers are employed to make a sensor array it is then possible to 
evaluate complex samples as mentioned in [87]. These sensor arrays can be part of a 
biological assay / electronic nose for a particular application depending on the sensitive 
layers that are chosen.  
 
To synthesize IDT structures, the equations formulated earlier were used [88]. The 
main idea is changing the dielectric medium between the fingers of interdigitated capacitor 
and due to this effect, effective dielectric constant of this area changes. This directly 
changes the total capacitance of interdigitated capacitance. Figure 2-1 depicts the 
equivalent circuit of the interdigitated capacitor. Magnetic coupling between the fingers, a 
transformer with the self-inductances L1 and L2 and the mutual inductance M is used. The 
capacitances Cp1 and Cp2 represent the stray fields from the fingers to the ground plane. 
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The ohmic losses that occur due to the current flow through the fingers can be described by 
two frequency dependent resistors Rf1 and Rf2. There resistances must be decreased for 
instance using thicker metal layer to get rid of losses. The modification of IDT surface 
during immunoassay process will increase the probe layer thickness on IDT fingers which 
influences the surface conductive and capacitive properties and hence the variations of 
parameter, Cg will be more dominant. 
 
Figure 2-1: Schematic of the electrical model of a two port, interdigitated capacitor. 
2.1 Modeling 
Interdigitated transducing (IDT) structures were designed for the impedimetric 
measurements and most IDT exist as multi-finger type of capacitors which are widely used 
in microwave and RF applications [89]. Protein molecules are able to express their 
biological functions only in frequency ranges less than 1 GHz [90]. To capture the 
biological activity, avoid structural resonance during the impedimetric measurements and 
to have resonance between 3-4 GHz, the IDT as shown in Figure 2-2 is designed. The 
capacitor itself is defined between the two ports. The IDT was designed to have 24 finger-
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like structures with dimensions of 800 µm in length, 40 µm in width with a pitch of 40 µm. 
The grounding arm around the interdigitated structure is of 400 µm in width. 
 
Figure 2-2: Schematic of two-port interdigitated capacitors. 
The simulation of structures shown in Figure 2-2 at high frequencies is not easy and 
electromagnetic simulators like MOMENTUM/HFSS should be used for high accuracy. In 
this work, modeling and simulation of IDT is performed using ADS (Advance Design 
System) MOMENTUM®. The structure, shown in Figure 2-2 is simulated with silicon as 
substrate and gold as the transducing metal in the frequency range of 1 GHz to 5 GHz. One 
of the ports is grounded during the simulations. From the simulated Scattering parameters 
(S11) capacitance was extracted and plotted with respect to frequency (Figure 2-3). The 
structural resonance is observed around 3.2 GHz. Above that frequency, inductive behavior 
is observed. 
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Figure 2-3: Simulated value of capacitance vs. frequency of the interdigitated capacitor. 
Resonance is observed at 3.2 GHz. 
2.2 Fabrication of IDT Structures 
In the course of this work, either microglass slide substrates (7.5 X 5 cm2) or Si-SiO2 
wafers (Ø 100 mm) were used and depending on substrate/wafer type, etch stop or lift-off 
technique was employed for the patterning of sputter deposited metal layer. In the 
lithographic process of patterning IDT features, mylar mask was used and each 4 inch 
wafer can accommodate 45 IDT structures whereas glass substrates accommodate 8 IDTs. 
Each IDT structure was designed to have 24 finger-like interdigitated electrodes with 
dimensions of 800 µm in length, 40 µm in width with a pitch of 40 µm within a total active 
area of 2.5 mm2. 
2.2.1 Fabrication by Etch Stop Technique 
To pattern metal on glass wafer, this technique is applied. Firstly, micro glass slides 
were cleaned with 3:1 piranha solution at 1300 C. Next, a very thin tungsten layer of 20 nm 
and gold layer of 200 nm thick were sputter deposited on the glass surface. Next, 1.8 μm 
thick positive photo resist (HPR 504) is spun over the glass surface. Following this step the 
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glass slide was exposed to UV with a dose of 100 mJ/cm2 and then developed using 
positive developer (OPD 4280). Finally, the electrodes were patterned by etching, the gold 
using mixture of potassium iodide (KI) + iodine (I2) solution in 4:1 ratio, followed by 
etching titanium layer using mixture of ammonium hydroxide (NH4OH) and hydrogen 
peroxide (H2O2).  Figure 2-4 presents the fabrication process flow of the etch stop 
technique where as Figure 2-5presents the fabricated realized gold IDT structure on glass.  
 
Figure 2-4: Schematic representation of the process flow of the etch stop technique 
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Figure 2-5: A representative of fabricated gold interdigitated capacitor on glass substrate 
2.2.2 Fabrication by Lift-Off Technique 
To pattern metal on wafers other than glass lift-off technique has been used. After 
cleaning wafers with acetone, a 2.5 µm thick, dual tone photoresist (AZ 5214 E) was spin 
coated and patterned on the SiO2 surface by exposing. Next, metal was deposited using 
direct current (DC) sputter deposition. Following this step, acetone was used to lift-off the 
nickel. Figure 2-6 shows the photographic image of the gold-IDT patterned using lift-off 
technique which highlights the dimensions of the finger electrodes. 
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Figure 2-6: Photographic image of the fabricated (lift-off technique) IDT structure. 
2.3 Comparison of Modeled and Experimental results 
For comparison, Agilent S-parameter network analyzer (8720 ES) was used to 
measure impedance parameters (S11) of the realized gold-IDT on Si-SiO2 substrate. The 
resulting capacitance extracted from the measured S11 parameters was compared to the 
simulation results and it is observed that the capacitance value at 2.354GHz is found from 
the simulation as 1.829 pF, Figure 2-3 that is very close to measured value of 1.8 pF, 
Figure 2-7. Moreover, fabricated IDT resonates around the same frequency of the 
simulation model. Therefore, it is verified that the characteristic properties of the realized 
structure are in good agreement with the simulated model. 
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Figure 2-7: Measured value of capacitance vs. frequency of the interdigitated transducer. 
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Chapter III 
3. DESIGN, REALIZATION AND FLOW CHARACTERIZATION OF 
MICROFLUIDIC SYSTEM 
As discussed in Chapters 1 and 2, the conjugation of protein assays to metal 
interdigitated electrode was achieved in far higher densities than any other method for 
immunodetection. Our previous studies reveal that the label-free detection using IDT is a 
robust and stable technique to quantify disease markers [91-93]. Therefore, there should be 
more emphasis on integrating the transducing platforms with novel fluid transporting 
mechanisms (microfluidic system) rather than investigation of protein immobilization on 
IDT structures. The work presented in this chapter focuses on the development of a novel 
microfluidic system for immuno-analysis. The design facilitates parallel analysis of single 
disease markers with different concentrations or multiple disease detection at the same 
time.  
3.1 Design of Microfluidics 
The design of LOC consists of two stacked PDMS layers on glass layer. The middle 
PDMS layer is used for channel structures and wastage reservoirs, whereas with the 
application of hydraulic pressure (pressing with finger). The top PDMS layer is designed to 
deform over the wastage reservoirs of middle layer. Essential components of system are an 
actuation chamber and fluid channels. The actuation chamber is vented to the ambient 
through an air vent/venting hole. Figure 3-1shows the schematic of the hand-operated 
microfluidic system for immunosensing applications. The transfer of liquids is 
accomplished by the relaxing of the elastic deformation caused by the release of hydraulic 
pressure, which induces a thrust (negative pressure inside the channel). Thus, the driving 
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force utilized in this design does not require an external power source as in the case of an 
off-chip actuated micro-fluidic systems.  
 
 
Figure 3-1: Schematic representation of the realized microfluidic system. 
In static assay immunoanalysis, the incubation period to allow the reaction to occur 
on the transducer surface is essential. Thus for specific lab applications, the proposed 
system with a series of coordinated steps would allow incubation in addition to the 
complex experimental lab procedures such as loading of analytes or washing (cycle-1) and 
draining (cycle-2) processes, as seen in Figure 3-2. During the cycle-1, an analyte sample 
is loaded into the inlet ports. The sample spreads inside the molded wells due to the surface 
tension and stops at the well boundary. By pump actuation, the analyte will run onto the 
gold-IDT. The channel and the IDT surface will be washed by repeating cycle-1 with wash 
buffer (1X PBS). After the completion of cycle-1 process, the sample analyte or washing 
solution will be collected in the waste reservoir. During cycle-2, the inlets ports were 
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closed and the reservoir is emptied through the air vent. Thus, the two processes (cycle-1 
and cycle-2) facilitate all lab procedures for immunosensing applications. 
 
The reversible van der Waals contact of PDMS-PDMS is used in closing and 
opening of all ports (inlet and air vent) with an additional PDMS cover layer. First, the 
analyte sample is loaded into the inlet well connected to channel. After opening the air 
vent, hydraulic pressure was created by pushing down the actuator on the wastage reservoir 
chamber. Next, the closing of air vent using a removable PDMS cover layer and release of 
hydraulic pressure creates a negative pressure inside the closed channel and sucks the 
analyte sample into the channel, hence onto the surface of IDTs. The same mechanism is 
used for washing the channel and sensor surface (Figure 3-2(a)). The loading and washing 
steps fill the reservoir chamber which will be sprouted through the air vent by placing the 
same cover layer on the inlets (Figure 3-2 (b)). 
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Figure 3-2: The operating mechanism of the immunosensing LOC. (a) Step 1: the analyte 
sample/wash buffer (20 µl) is dropped to fill the three inlets. Step-2: without 
closing the air vent with cover layer, a hydraulic load is applied by pressing the 
actuator with finger. Step 3: The actuator is released with load after closing the 
air vent with a cover layer and after few seconds the cover layer is removed to 
stop the fluid flow action for incubation. (b) Step 1: open the air vent and close 
the inlets with same inlet cover layer sequentially. Step 2: A hydraulic load is 
applied on the actuator to drain the collected waste through the air vent. 
3.2 Modeling of the Microfluidic Device 
The actuator was modeled as a circular diaphragm with clamped edges under a 
uniform load/mechanical pressure in the lateral direction (z). Since the thickness of the 
actuator (t) was smaller than the diameter (2a), we assume that the actuator layer thickness 
would not change during operation. The actuation process is schematically shown in Figure 
3-3and the displacement along the radial direction (deflection, w) can be expressed as,  
[94] 
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From eq. 3.1 we can obtained 
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by changing the limits and substituting eq. 8.5 in eq. 8.4, the volume change can be written 
as  
[ ]∫ =−= a aDqdrrarDqV 0 6223 192644π  (3.6) 
 
Therefore, the volume flow rate of the actuator can be expressed as  
 
6625.0602 af
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where, 60 is the conversion constant from the unit of volume change per second to the unit 
of volume change per minute; fc is the frequency of the pumping motion of the actuator, 
which strongly depend on material property and external load. Table 3-1 shows the 
theoretical maximum volumetric flow rate, the designed micropump can deliver. 
Table 3-1: Deliverable volumetric flow rate of the designed micro pump 
Actuator type Radius (mm) Thickness (mm) Max. volumetric flow rate (µL/min) 
Circular 10 2 29.16 
 
To initiate the flow in the channel it is assumed that the change in volume of 
actuating chamber during the application of hydraulic pressure is larger than the total 
channel and inlet port volume. Therefore, the negative pressure created after release of 
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hydraulic load decreases the fluidic resistance in the micro channel running over the IDTs, 
hence enables the sample to flow through the channel from inlet ports.  
3.3 Fabrication of Microfluidic system  
The glass substrates were pre-patterned with gold electrodes by using the etch stop 
fabrication process as mentioned in Chapter 2. The microfluidic section of the LOC was 
realized in polydimethylsiloxane (PDMS) by soft lithography. The channels and actuators 
were microfabricated through coordinated casting, curing and bonding processes of 
PDMS-PDMS and PDMS-glass. The microfluidic channels used to transfer the analyte 
samples and incubation wells over the IDT area were formed of PDMS. A 3 mm thick 
PDMS layer was dispensed onto a pre-patterned SU8 master supported on a silicon wafer 
and degassed for 2 hrs. After curing the elastomer for 1 hr at 80 0C, the replica layer was 
peeled off from the masters and the hole for main actuator was punched out. Each of the 
incubation well has an enclosure cavity of 0.1344 mm3 in volume. The channel lines are 
rectangular in cross-section which is 100 μm wide by 60 μm deep. A second layer of 
PDMS was again dispensed onto the blank wafer to act as an actuator and the same casting 
process was used while the thickness of this layer is ׽ 1.5 mm. The microfluidic channel 
was then sealed by bonding the punched PDMS layer to a pre-patterned glass substrate 
with a 30 sec oxygen plasma treatment to activate both surfaces prior to the bonding 
process which was repeated to seal the second PDMS layer over the punched-out PDMS 
layer. The whole assembly was cured for 1 hr at 80 0C. Finally, after punching out the inlet 
and air vent ports, covered with a PDMS layer (׽ 1.5 mm) which make a reversible bond. 
Figure 3-4 shows the fabrication process of the microfluidic. 
 
27 
 
 
Figure 3-4: Fabrication process flow the PDMS-based microfluidic system with pre-
patterned glass as substrate for immunosensing applications. 
Figure 3-5 shows the photographic image of the fabricated fluidic system which is of 
60 X 45 X 5.5 mm3 in dimensions. Insight shows a magnified image of IDT; each planar 
structured IDT constitutes an array of 24 gold interdigitated electrodes (GIDT) within an 
area of 1.4 X 1.8 mm2. 
 
28 
 
 
Figure 3-5: Photographic image of the fabricated PDMS-based microfluidic system with 
pre-patterned glass as substrate. 
3.4 Flow-rate Analysis of the Microfluidic system 
The liquid flow rate was analyzed for the release of applied hydraulic load.  A high-
speed, digital CCD camera (Phantom V311), which can run up to maximum of 500,000 
frames per second was used to gather the images. The experimental setup to analyze the 
flow-rate is shown in Figure 3-6. The majority of the images are recorded at 1000 fps and 
the lens used is a macro lens with a field of view up to 2.8 mm at a focal length of 15 cm. 
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Figure 3-6: Photographic representation of the experimental setup used for the flow 
characterization. 
The working fluid (a blue dye) was driven from the inlet liquid reservoir using 
internal actuator action (cycle-1). We measured the flow rate of the system by releasing the 
applied load. It is observed that the working fluid flows into the wastage reservoir through 
the channel because the released hydraulic load decreases the fluidic resistance of the 
channel over the ambient. When the actuator is released by removing the pushed down 
finger, the measured average flow rate in the channel is 300 nl/sec, which is very lower 
than the previous experimental value (15.4 µl/sec) [72]. Thus, from this experimental 
observation, the physical washing of the chemical species on the IDTs be ruled out.  
 
We have also observed that, the flow behavior depends only on the internal thrust 
created inside the channel due to the relaxing of the actuator. Moreover, the internal thrust 
created by the actuator can suddenly be released by removing the cover layer from the air 
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vent. Thus, both ends of the channel were open to ambient which minimizes the pressure 
difference and hence liquid flow stops over the IDTs. Thus, this facility of the fluidic 
system is proved advantageous in LOC applications where incubation is necessary for 
chemical complex formations.  
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Chapter IV 
4. LAB-ON-A-CHIP FOR MULTI-TARGET IMMUNOSENSING 
APPLICATIONS 
The results presented in Chapter 3 demonstrated that fabricated fluidic system can be 
used as LOC for immunosensing applications. To build upon the work described in 
Chapter 3, an experiment was conducted on fluidic system for multi-target immunosensing. 
Fluid was transferred without any external source by the release of micropump actuated by 
hydraulic pressure (by pressing with a finger). Interdigitated transducer (IDT)-based 
affinity-type sensors were employed for the detection and quantification of target 
molecules in complex mixtures by affinity-based interactions. A single integrated micro-
pump is operated to perform all necessary washing and surface modification procedures. 
The function of the hand-operated fluidic system as a LOC was tested with two target 
biomarker protein models, such as human epidermal growth factor (hEGFR) and 
interleukin (IL-6) antibodies. Each LOC consists of eight IDTs, three inlets and an air vent 
(Figure 3-5). Additionally, three integrated microfluidic channels each of 100 µm width 
were connected to the inlets and the actuating chamber which passes over the IDT surface.   
4.1 Surface Modification of Transducer 
The first stage in the development of immunosensing LOC was to optimize the 
thiolization of the metal electrodes for the immobilization of protein. The protocols 
developed for the stable immobilization were presented in Appendix A (optimization of 
linker chemistry). The IDT surface was covalently modified with thiol linkers by self 
assembly approach, which gives uniform layer of the linker molecule and the maximum 
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sample surface coverage. The IDT surface was then positively charged by activating with 
EDC-NHS coupling, which readily binds protein antibodies.  
4.2 Immobilization of antibodies 
The SAM (MUDA) coated gold-IDT (GIDT) surface was activated using a mixture 
of 0.1 M EDC and 0.05M NHS (1:1). Both reagents were prepared in sterile deionised 
water and immediately mixed before use. Activation of each IDT was performed through 
microfluidic channels of the system by cycle-1 process. After 4 hour incubation, the sensor 
system was then washed with PBS buffer and antibody immobilization was performed. 
Triplicate IDTs were coated with 30 µg/ml concentrations of anti-hEGFR and IL-6 
antibodies in buffer. After the antibody immobilization process, the sensing platform was 
washed with PBS and subjected to antigen binding along with appropriate controls. 
 
 
4.3 Multiple protein marker detection 
Multiple protein marker detection was performed using microfluidics system 
fabricated as described in Chapter 3. hEGFR and IL-6 markers were used as target 
biomarker proteins for simultaneous detection of cancer and cardiac diseases. In a healthy 
individual, the normal level for hEGFR is lower than 8 ng/ml and for IL-6, it is lower than 
100 pg/ml. Any level higher than the specified would drastically increase the risk of cancer 
and cardiac diseases [95-97].  The EGFR (cancer marker) and IL-6 (cardiac marker) levels 
were detected in the concentration range of 0.1-10 ng/ml in human serum. 10 ng/ml of each 
marker was prepared in 100% human serum and lower concentrations were then diluted 
from the stocks using normal serum. 50 ng/ml of BSA protein was used as negative control 
on the antibody immobilized surface to validate the specificity of the binding between 
target antibody-antigen pairs. Each concentration of the markers was measured in three 
parallel and triplet measurements using network analyser for accuracy and error analysis. A 
two hour incubation time was applied at the antigen binding step and the microfluidic 
system was then carefully washed with PBS and dH2O prior to taking measurements. The 
functionalization of the IDT surface is schematically shown in Figure 4-1. 
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Figure 4-1: Schematic diagram of the bio-functionalization of the IDT surface. 
4.4 Electrochemical Measurements 
Impedimetric electrochemical measurements were performed using network analyzer 
(Via echo 2500) which is portable and designed to operate between 4 MHz and 2.5 GHz 
[98]. Triplet measurements were taken for each IDT of the LOC in the frequency range of 
50 - 300 MHz and inter-assay analysis was performed. The S11 parameters during surface 
functionalization and the immobilization were recorded. For the analysis, capacitance was 
deduced from the S11 parameters. Figure 4-2 shows photographic image of the 
electrochemical measurement setup. The deduced capacitance after antigen binding was 
normalized with the values obtained from the respective antibody immobilization and the 
results were analyzed as the normalized capacitance change (|ΔC|).  
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where C and CO represent the capacitance after target binding and antibody 
immobilization. 
 
Figure 4-2: Photographic image of the hand-held format of measurement system. 
4.5 Immunosensing LOC performance 
The specificity of the sensor to hEGFR and IL-6 were derived from the specific 
binding between the anti-hEGFR-hEGFR antigen, anti-IL-6-IL-6 antigen and no binding 
with BSA, the negative control. In Figure 4-3 and Figure 4-4 we have observed a 
significant change in |ΔC| for the hEGFR antigens (scan range: 230-280 MHz) and IL-6 
antigens (scan range: 140-200MHz) concentrations. Further, it was found that the antigens 
were clearly detected in the concentration range of 0.1 to 10 ng/ml. 
 
The target antigens interact and bind to the specific antibody by which they achieve 
certain active and vibrating three dimensional (3-D) conformations [99-100]. Thus, the 
35 
 
vibrations lead to the transfer of charges in the 3-D structure which predominantly 
contribute to the frequency and consequently to the observed function. Hence, the 
frequency of conformational vibration strongly depends on size of the 3-D structure and 
surface charges that vary from one protein to another. For instance, the hEGFR (324 amino 
acids) [101-102]is larger in size to IL6 (184 amino acids) [103]. Thus, the response of 
IDTs treated with hEGFR protein is consistent in the range of 230-280 MHz whereas other 
IDTs were consistent in the range of 140 to 200 MHz. Furthermore, with standard 
experimental conditions (geometry of the IDTs and immobilization procedure), the |ΔC| 
levels of IDTs with hEGFR complex are higher when compared to the responses of IDTs 
with IL-6. Hence, the binding of an analyte to an immobilized molecule can be detected 
without labeling or secondary reactions using IDT measurements.  
 
Figure 4-3: Relative change in capacitance obtained after anti-hEGFR immobilized IDTs 
were incubated with various concentrations of hEGFR antigens in serum in 
frequency range of 260-280 MHz.  
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It is observed from Figure 4-3 and Figure 4-4 that the binding/reaction process 
involves a number of induced interactions between proteins (hEGFR and IL-6) and their 
respective antigens. These interactions are highly selective, and this selectivity is defined 
within the protein primary structure. The R1 and the R2 groups in any of the amino acid of 
hEGFR/IL-6 [104] symbolizes alkyl side-chains, determining the electrical properties.  
These R-groups are polar in nature [105] and the net charges vary with the interaction of 
the R-group of anti- EGFR/IL-6 body with R- group of specific antigen and therefore 
undergo local polarization process which influences the dielectric permittivity of the 
surface. Therefore, the induced vibrations of the formed 3D structure due to the protein 
binding lead to displacement of surface charges and cause a local disturbance of the 
distribution of bound charges will occur at the dielectric interface [106] and these charges 
move under strong confinement termed as dipole moment [105]. However, the physical 
nature of these interactions is not yet well understood. Therefore, a hypothesis has been 
developed in which the specific antibody-antigen interaction results in the polypeptides to 
be chained in form of strings of connected dipoles; these dipole – dipole interactions 
stimulate polarization on the sensor surface. The polarization cannot be measured directly 
[107]; so a dielectric theory is invariably linked to polarization effects. The relation of the 
antibody-antigen interactions with the dielectric properties is interpreted with the Cole-
Cole model [108].   
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Figure 4-4: Relative change in capacitance obtained after anti-IL-6 immobilized IDTs were 
incubated with various concentrations of IL-6 antigens in serum in frequency 
range of 140-200 MHz. 
 
4.6 Detection analysis 
4.6.1 Change in Dielectric Properties Induced by Antibody-Antigen Interaction 
An IDT operates in a way that is very similar to a conventional parallel plate 
capacitor where dielectric properties give information such as conductivity and permittivity 
of the medium. The detection principle of conductivity and permittivity of medium is 
based on capacitive coupling of the excitation signal produced by IDT electrodes [109]. 
Thus, the electric field lines always penetrate into the medium regardless of the position of 
the electrodes (parallel or co-planar) [109]. Depending on the geometric configuration of 
the electrodes, the electric field lines can penetrate deeper with wider electrode 
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configuration [109]. Therefore, the capacitance of the IDT always depends on the 
geometry of the electrodes which is constant and the dielectric property of the medium. 
While developing immunoassay on the IDT surface, different biochemical layers are 
coated which increases the probe layer thickness and all biological samples have an 
arrangement of electric charge carriers [110]. These charges are displaced by an external 
electric field and polarized to neutralize the effect of the external electric field. This 
dielectric response of each protein over the frequency spectrum is unique characteristic for 
each of its kind [111].  
 
The dielectric response of any material is represented in terms of its complex 
dielectric permittivity ε* [112] and it is given as  
 
"' εεε j−=∗      (4.2) 
 
where the real part of permittivity ε΄ is called dielectric constant and is a measure of energy 
stored from an external electric field in a material. The imaginary part of permittivity ε˝ is 
called the loss factor and is a measure of the energy loss to an external electric field. The 
loss factor is actually expressed as a function of both dielectric loss and conductivity and it 
is given as    
 
⎥⎦
⎤⎢⎣
⎡ +−=∗ ω
σεεε "' dj    (4.3) 
 
where ε˝d is dielectric loss and σ is conductivity. Depending on their relaxation frequency 
σ/ωε, a material falls into two categories: conductive material or dielectric material [112]. 
In general, when σ/ωε>>1, the material is considered as a good conductor or lossy 
material. Similarly, the material is considered dielectrics or low-loss material if σ/ωε<<1. 
Therefore, the intrinsic nature of the biochemical species would affect the imaginary part 
of dielectric permittivity and hence the dielectric property of the coated medium changes. 
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However, the structure and nature of most protein/biological molecules are not defined to 
the extent and direct measurements for complex dielectric permittivity are hard to achieve 
[107]. Alternatively, the relationship between ε΄ and ε'' with frequency ω as the 
independent parameter can be estimated using Cole-Cole model. It should be noted that 
even when the conductivity of a material is zero, its complex dielectric permittivity may 
have a non-zero imaginary part. The non-zero imaginary part is responsible for the energy 
dissipation process due to dipole re-orientation and translational motion of charge carriers 
[113].   
4.6.2 Cole-Cole model for the detection of EGFR and IL-6 proteins 
The Cole – Cole model has been successfully used to describe the experimental data 
for the dielectric constant of many biomaterials as a function of frequency [114]. The 
imaginary dielectric permittivity depends mainly on five parameters: the static impedance 
Ro, the impedance at infinite frequency R∞, the relaxation time constant (τo), polarizability 
(m) and an exponent factor c [114]. In principle, Ro and R∞ can be calculated from 
measured S11 parameters by finding global minimum and global maximum, and the other 
three parameters τo, m and c have to be treated as fitting parameters whose values can be 
retrieved from the best fit to the experimental data using MATLAB (Appendix B). Thus, 
the spectral response was reckoned by an equivalent circuit model with discrete elements, 
as presented in Figure 4-5. The impedance of the equivalent network is given in equations 
4.4-4.6. Using the equations an algorithm in MATLAB has been developed to obtain the 
Cole–Cole parameters from experimental data.  
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The data for each protein at each stage (before and after complex formation) were 
fitted separately and the fitting parameters owing to the specific antibody-antigen 
interaction are shown in Table 4-1. By comparison, the polarizability/chargeability (m) for 
anti-IL-6 (antibody) is the lowest (m=0.1623) as the size of protein is small and increases 
after binding with IL-6 antigens (m=0.5548) which consistent to the increase in charge 
distribution upon antigen-antibody complex formation. The same trend was observed with 
hEGFR protein, whereas with the control protein (BSA) target binding did not occur. This 
infers that anti-hEGFR/IL-6 do not have receptors for control proteins. Moreover, this 
complies with the theoretical concept that the polarizability after antigen-antibody 
interactions should increase as surface conduction properties associated with the movement 
of protein bound charges change under the applied electric field [105]. The behavioral 
response from Cole-Cole model and hypothesis of variation of polarizability can be well 
correlated to the previously reported studies [116-117].  
4.7 Kinetic analysis of hEGFR and IL-6 proteins Binding on Sensor Surface 
The affinity of the sensor surface immobilized with anti-hEGFR and anti-IL-6 
binding to their respective targets was determined by non-linear regression analysis. The 
extracted dissociation constants (Kd) were within the highest concentration of targets 
applied (10 ng/ml) (Figure 4-6). The binding kinetics of the antigen and the antibody 
interaction was dependent on avidity i.e., the synergistic binding affinity of multiple 
interactions. The binding affinity can be significantly increased when multiple protein sites 
are available for binding. The lower the Kd value the stronger the binding according to the 
Langmuir adsorption isotherm [118]. Here, IL-6 showed strong binding compared to 
hEGFR. Thus, the density of the available binding sites greatly impacted the avidity effect, 
resulting in an apparent affinity between the protein and target when binding sites are 
clustered in a close proximity. Thus, higher concentrations of target would not increase the 
effective area density of the proteins or binding to specific antigens because of saturation 
of binding sites. Hence, we observed saturation occurred at target concentrationsof8 ng/ml 
and 5 ng/ml for hEGFR and IL-6, respectively. The sensitivity of the IDT was dependent 
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on the specified amount of target bound within an area of 1.4 ° 1.8 mm2 sensor surface 
under standard condition with a defined geometry as described in experimental section. 
 
Figure 4-6: Dose-dependent change in relative capacitance occurred after the Ab-Ag 
complex formation on IDT surface against varying concentrations of hEGFR 
at 270 MHz and IL-6 target in serum (0.1 to 10 ng/ml) at 170 MHz frequency. 
In summary, the results presented above demonstrated the development of a sensitive 
and label-free immunoassay using a hand-operated LOC, which is to our knowledge, for 
the first time, shown for the detection of a cancer (hEGFR) and a cardiac (IL-6) marker on 
a single platform. This study demonstrates the development a novel LOC technology 
which does not require external power source/instrument for fluid transfers using the 
presented design and fabrication method. One of the main advantages herein is the use of 
low sample volume, simple multiple detection, fast fabrication process and adaptable to 
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long incubation periods in immunosensing applications, which the current available 
techniques fail to deliver [72, 119]. Thus, using label-free electrochemical-based 
immunosensing methodology, we have demonstrated the detection mechanism and 
sensitivity for hEGFR and IL-6 markers. Further, we have also modeled the detection 
behavior using dielectric relaxation method and model parameters were obtained. This 
model implies that the detection behavior or change in impedance upon antibody-antigen 
interactions dominates the changes in dielectric properties between the capacitive IDT 
finger electrodes. 
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Chapter V 
5. LABEL- FREE DETECTION AND QUANTIFICATION OF NAMPT 
PROTEIN USING ssDNA APTAMER 
The results presented in previous Chapter identify label-free detection methodology 
as an alternate and reliable immunosensing approach for the quantification of protein 
markers. We here extended the same approach for the determination of binding of single 
stranded deoxyribonucleic acid (ssDNA) aptamers and Nampt protein target on an IDT 
platform which contains 45 IDTs and each IDT works as an individual biosensor. Here, 
ssDNA aptamers served as affinity ligands that specifically capture/bind Nampt protein. 
These ssDNA aptamers were immobilized on gold IDTs and binding of Nampt to the 
immobilized aptamers on IDTs was measured using the label-free method. 
5.1 The Importance of Nampt Protein 
The plasma Nampt levels are reported to have relation with obesity [120] and obese 
related metabolic diseases, such as Type 2 diabetes mellitus (T2DM), cardiovascular 
diseases [121-122] and hyperlipidemia [123] due to association with lipoprotein and 
cholesterol. Moreover, Nampt was demonstrated to induce angiogenesis [124-125], hence 
some studies have shown the correlation between the expression of the Nampt and the 
various types of cancers[126]. For example, over expression of Nampt levels in colorectal 
cancer [127-129], prostate cancer [130-131], gastric cancer [132], and breast cancer [133] 
have been reported. In addition to these cancers and obese related diseases, various kinds 
of diseases like polycystic ovary syndrome [134], chronic kidney disease [135], chronic 
obstructive pulmonary disease [136] were also related. Therefore, Nampt was used as a 
target protein to develop a label-free aptasensor for the first time. 
45 
 
Many research groups are involved in detection of this multifunctional biomarker 
(Nampt) using enzyme linked immunosorbent assays (ELISA) [137-139]. However, 
antibodies used in the ELISA possess some limitations with instability and functional 
variations, and commercial ELISA with this antibody showed the discrepancies in clinical 
studies [140]. Alternatively, aptamers are artificial oligonucleotides (DNA or RNA) with 
the ability to recognize target molecules such as peptides, proteins, drugs, organic and 
inorganic molecules or even whole cells, with high affinity and specificity can be utilized 
for the biomarker detection. This specific recognition ability is conferred to these 
oligonucleotides by virtue of their primary sequence that folds into a 3D globular shape 
and specific for its target, here Nampt. Consequently, they have the chemical structure of 
DNA or RNA, but behave functionally as antibodies.  
5.1.1 Advantages of Aptamer-based Biosensor Development 
The aptamers show an affinity for their targets comparable to, and sometimes even 
better than, monoclonal antibodies [141]. They can also be selected against non-
immunogenic and toxic targets, because the Systematic Evolution of Ligands by 
EXponential Enrichment (SELEX) process to produce aptamers does not rely on the 
induction of an animal’s immune response, as is the case with antibody generation [142]. 
Aptamers are also very flexible. They can be easily labeled with reporter molecules, such 
as fluorophores/enzymes and can be immobilized onto a surface, provided that the affinity 
for its target is not affected [143]. As other important aspect, apart from their high target 
affinity and the advantages described above, aptamers provide reusable affinity-based 
biosensors, which was the major obstacle for the routine implementation of 
immunosensors [144]. They can be easily regenerated by treatment with a denaturing agent 
to break the aptamer-target complex [143]. When an aptamer is used as the biological 
recognition element of a biosensor, it is termed an ‘aptasensor’. Thus, with the aptamer 
stability and consistent working, many platforms that implemented the aptamer have been 
reported in order to develop stable biosensor such as piezoelectric quartz crystal 
microbalance biosensor [145], microfluidic device [146], surface plasmon resonance 
biosensor [147] and gold nanoparticle based biosensor [148]. 
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In the process of developing a label-free, affinity-based Nampt aptasensor, the 
following amine modified Nampt specific ssDNA aptamer with the following sequence 
was used :5’-NH2(CH2)6ATACCAGCTTATTCAATTGGGCAGGACAGGTGTCGGCT 
TGATAGGCTGGGGTGTGTGTAGATAGTAAGTGCAATCT-3’that was previously 
selected by FluMag-SELEX method [149] in our collaborator’s laboratory in South Korea.  
5.2 Fabrication and Surface Modification of IDT arrays 
The gold-IDT structures were patterned on Ø 100 mm silicon-silica (1µm) wafer 
using the lift-off technique described in Chapter 2. The Nampt specific aptamer (5 µM) 
was functionalized on the gold-IDT surface using protocol described in Appendix C. 
Figure 5-1 shows the IDT structures while being functionalized. Various concentration of 
the Nampt target protein (0-250 ng/ml) in binding buffer as well as serum was incubated 
for 1 hour with the Nampt specific aptamer immobilized onto the IDT arrays. For the 
confirmation of the specific detection of the aptamer, negative control samples with non-
specific proteins such as RBP4, vaspin and BSA were also incubated under identical 
conditions.  
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Figure 5-1: Photographic image of the Ø 100 mm Si-SiO2 wafer with patterned gold-IDTs. 
Each wafer consisted of 45 IDT structures and can be used as an individual 
biosensing surfaces and replicates. 
5.3 Electrochemical Measurements 
For electrical measurement of the dielectric parameters (impedance/capacitance), 
Karl-Suss (PM-5) RF probe station and agilent-8720ES S-parameter network analyzer 
were used. The agilent 8720ES is a desktop network analyzer operates between 50 MHz 
and 20 GHz. The scanned frequency range was between 50MHz and 1GHz. The network 
analyzer was calibrated using SOLT (short-open-load-through) method and S-Parameter 
data of the sensor were measured. The S11 parameters were measured at different stages of 
surface modification processes. First, the parameters were measured with (a) blank IDT, 
(b) IDT after SAM formation with the aptamer and ethanolamine blocking, (c) after 
capturing of various concentrations of target and counter target on the aptamer-
immobilized IDTs. All measurements were performed in triplicates for the meaningful 
statistical error analysis. The parameters were exported to Matlab and capacitance 
components were extracted for the analysis. The changes in capacitance or dielectric 
properties were compared (signal from blank, control, and after target capturing).  
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The percentage relative capacitance variations were calculated from the generated 
data obtained within the 400–1000 MHz frequency range under standard assay conditions 
using equation (5.1). 
 
100arg00 ∗−=Δ
control
controlett
C
CC
C
     (5.1)
 
where Ctarget is the capacitance after the binding of the Nampt target with SS DNA aptamer 
at a particular concentration and Ccontrol is the capacitance before binding.  
5.4 Response of Nampt in Buffer 
The IDT-based biosensor showed consistent dose-dependent behavior in the range of 
400-650 MHz frequency (Figure 5-2) for the detection of the Nampt in buffer and this 
range was selected for the analysis. In this frequency range, biosensor chip showed 
concentration dependent response only for the main target Nampt from 1 ng/ml to 50 
ng/ml. The concentration higher than 50 ng/ml of Nampt did not show significant response 
probably due to the saturated binding sites of the sensor surface. This may also have arised 
from the competition between the captured Nampt and the free Nampt to bind on the 
sensor surface containing immobilized aptamers. The limit of detection of this capacitive 
biosensor was determined to be 1 ng/ml and a dynamic range was from 1 to 50 ng/ml 
according to the linear fit derived from the extrapolated data points. With the view of the 
clinical insight, this range can be considered to be in the clinical range because the 
concentration of the Nampt in the patient suffering from T2DM is around 31.9 ng/ml and 
the normal concentration is 15.8ng/ml [150]. To our knowledge, this is the first report 
showing the lowest range for the Nampt detection using ssDNA aptamer. 
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Figure 5-2: Relative percentage change in capacitance obtained after Nampt ssDNA 
aptamer immobilized IDT’s after incubation with various concentrations of 
target in buffer. Inset figure shows a dose dependent change after the complex 
formation with varying concentrations of Nampt target in buffer at 500 MHz 
frequency. 
5.5 Response of Nampt in Serum 
While  many  sensors  exhibit  promising  properties  in  aqueous  buffer solution,  
only  few  of  them  maintain  their  analytical  properties when  exposed  to  serum  
samples because serum contains large amount of different proteins and other biological 
molecules. Detection of a specific protein such as Nampt that exist in small concentration 
is challenging task. However, in this study, our work focused on detection of Nampt in 
complex serum utilizing the modified protocol that eliminates non-specific molecules 
simply by washing away with appropriate buffer. This also ensured that only Nampt 
protein was able to bind to aptamers on the IDTs surface. For this, initially, the Nampt 
specific aptamer immobilized GID capacitor arrays were incubated with various 
concentrations of Nampt (1-250 ng/ml) spiked in serum. After the incubation in serum 
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containing different concentration of Nampt, which specifically bind to ssDNA aptamers 
leaving behind the non-specific serum proteins that were washed away using PBS buffer 
and dried. These dried sensor surface were subjected to impedimetric measurements. As a 
result, we observed dose dependent relative Nampt specific capacitive responses as a 
function of frequency (Figure 5-3) without false positive signal. The binding of serum 
spiked with the target Nampt with specific aptamer was achieved after the formation of 
Nampt-aptamer complex due to the alternatively charged side chains of amino acids in 
proteins and negatively charged ssDNA backbone [105]. The complex formation yield net 
charge distribution on the GID surface and therefore undergo local polarization, hence 
influence the dielectric properties on the sensor surface [108].  
 
Figure 5-3: Relative percentage change in capacitance obtained after Nampt-ssDNA 
aptamer complex formed on IDTs after incubation with various 
concentrations of Nampt target in human serum sample. 
5.5.1 Binding kinetics of ssDNA aptamer-Nampt in serum 
Dose dependent analysis was performed with the help of Sigmaplot 10.0 program 
assuming Langmuir adsorption isotherm and determination of affinity/dissociation constant 
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(Kd). The change of the capacitance against various concentrations of the Nampt spiked in 
human serum was determined after incubating on IDTs with constant amount of ssDNA 
aptamer. The capacitance response at four constant frequencies within the active frequency 
range was chosen for the analysis (Figure 5-3). The kinetics of the binding reactions 
between ssDNA aptamer and the target (Figure 5-4) were further supported by the 
characteristic responses of the bound complex to the applied frequency, hence the 
rotational relaxation time. The larger size/volume of the accumulating protein layer on the 
capacitive biosensor surface tends to possess larger relaxation times arising from the 
rotation of the protein molecules. Thus, the non-linear regression analysis confirms the 
behavior of protein molecules including relaxation of proteins, and surface conduction 
processes associated with movements of protein bound ions in a particular range of 
frequency [106]. The data were fitted to non-linear regression analysis and the dissociation 
constant assuming one aptamer binding to one target (ligand binding) was calculated to be 
29.95, 33.37, 24.10 and 16.73 ng/ml at 700, 800, 900 and 1000 MHz, respectively. The 
calculated dissociation constant suggests that maximum avidity was observed between 900 
to 1000 MHz of frequencies. Therefore, that frequency range could be termed as activity 
range for Nampt. Moreover, the aptamer and the target interactions were further verified 
using the Cole-Cole model confirming the measured response was in accordance with the 
theoretical model.  
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Figure 5-4: Dose dependent change in relative percentage change in capacitance. The 
response occurred after the aptamer-target complex formation on IDT surface 
against varying concentrations of Nampt target in serum, at four different 
frequencies indicated in the figure legend. 
 
The data for Nampt aptamer at each stage (before and after target binding) was fitted 
separately and the fitting parameters owing to the specific target binding interaction, is 
shown in Table 5-1. The fitting parameter for polarizability did not vary much with control 
targets whereas the levels with Nampt target elevated, inferring that moment of charges 
between the ssDNA backbone and the targets occurred. Moreover, the polarizability after 
Nampt target binding in serum is higher than target bound in buffer. This is because, serum 
contains many other charged constituents that may have persisted and contributed to the 
surface charge distribution despite of washing away all non-specific molecules. However, 
for the analysis, this non-specific signal was also used to normalize with the data obtained 
from appropriate negative controls under standard assay conditions. 
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Table 5-1: Cole-Cole fitting parameters with specific interactions of Nampt ssDNA 
aptamer with its respective target. 
 
 
The label-free methodology developed for the detection of Nampt in this study can 
be captured at detection limit concentrations as low as 1 ng/ml with dynamic range from 1-
50 ng/ml, which can cover the clinically important level because the plasma level of the 
Nampt is 15 ng/ml.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Aptamer 
(Target bound) 
Polarizability 
(m) 
 
Relaxation time 
constant (τo10-10 sec) 
Resistance (Zo) 
Nampt target 
(buffer) 
0.639 9.28 5.258 
Nampt target 
(serum) 
0.813 14.82 4.149 
Nampt ssDNA 0.151 3.14 7.961 
Control 0.162 2.89 7.257 
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Chapter VI 
6. ALTERNATE ELECTRODE MATERIALS FOR BIOSENSOR 
APPLICATIONS 
Many challenges still remain with respect to commercialization of sensors and bulk 
cost and the transducing electrode material is one of them. The work presented in this 
Chapter focuses on the development of a thiol monolayer on other cost-effective, alternate 
metals and to verify its immunosensing capabilities. The main challenge remains for metal 
electrodes that are made other than gold. The formation of adherent and well-ordered SAM 
[151] on such metals is a key issue and requires a strong interaction between the substrate 
and the reactive moieties of the organic molecules in the form of a film. Researchers 
successfully developed protocols for selectively immobilize biomaterials onto solid-state 
(electrode) surface of the sensors / transducers. With this aim, there has been considerable 
effort devoted for alkanethiols self assembled monolayers (SAMs) on gold surfaces and 
functionalizing those surfaces with carbon nanotubes (CNTs) [152-154], nanoparticles 
[152, 155-157] for biosensing applications. In spite of existence of numerous experimental 
investigations in the area of biosensors, the material selection for the transducing platform 
and the optimization in fabricating the transducers have not been well studied yet. 
Therefore, nickel was considered to be a cost effective alternative to conventional/gold, as 
a generic transducing platform for biosensing applications. For the first time to detect 
cardiovascular risk markers, nickel was employed as an electrode material that has higher 
durability and lower cost.  
As explained in Chapter 2, the sputtered nickel was patterned as IDT structure 
(Figure 2-2) using image reversal process on Ø 100 mm Si-SiO2 wafer. The surface of the 
transducing surface was modified with the in-house developed protocol (Appendix A) and 
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for the immunoanalysis, CRP protein antibodies were immobilized. As performed in 
Chapter 5, the same experimental procedure was adapted and S11 parameters were 
measured at different stages. Interestingly, the nickel IDT structures have shown no 
structural resonance between 50 MHz and 20 GHz (Figure 6-1). This is because, in low-
frequency region, the impedance parameter is practically constant. Thereafter, at medium 
frequencies, due to the concentration of the current (i.e., reduction of the effective 
conductor cross section), the capacitive behavior tends to decrease. This current 
concentration modifies the magnetic field in the space between the nickel finger structures 
and hence reduces the external inductance. Simultaneously, the magnetic field within 
fingers is reduced, resulting in a decay of the internal inductance, which contributes to the 
decay of the total inductance. At high frequencies, when the edge, proximity and skin 
effects are fully pronounced, the inductance per unit length tends to a constant value [158]. 
 
Figure 6-1: Capacitance measurements of Nickel IDT patterned on Si-SiO2 substrate. 
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However, in the scope of this work, the coated SAM layer was first verified with FT-IR 
and from the analysis developed in section 2.1, measurements were taken between 50MHz 
and 4 GHz. The parameters were exported to Matlab and impedance (no inductance was 
observed) components were extracted for the analysis. The deduced impedance after 
antigen binding was normalized with the values obtained from the respective antibody 
immobilization and the results were analyzed as the normalized impedance change (|ΔΖ|) 
(same as equation 4.1 with impedance Z). However, further characterization of the Nickel 
based IDTs is required to potentially use for biosensing applications. 
6.1 Verification of SAM layer 
The formation of SAM layer and surface activation of IDT surface was verified by 
recording Fourier Transform Infrared (FT-IR) spectrum and correlated with reference 
spectra [159]. All spectra were collected with 64 scans for the reference and the sample, 
with 4 cm-1 resolution in the reflection mode. The FT-IR spectra obtained from MPA SAM 
surface is shown in Figure 6-2(a). Since MPA contains the CH2 back bone, its spectrum 
shows CH2 symmetric and CH2 asymmetric stretch modes around 2855 and 2950 cm-1.  
The spectrum also reveals an out of plane mode rocking vibration of CH2 bond [160-161] 
at 740 cm-1. The disappearance of the band at 2551.5 cm-1, corresponding to S-H band 
stretch is an indication that the MPA is being adsorbed on nickel surface through the 
sulphur group [161]. The stretch at 1150 cm-1 corresponds to anti symmetrical coupling 
between C-O to C-C. Next, the SAM surface was activated by incubating EDC-NHS 
mixture on MPA. The FT-IR spectrum of the activated surface is shown in Figure 6-2 (b). 
The two features between 1500-1700 cm-1 correspond to the formation of ester [162]. The 
spectra also reveal the formation of a bend vibration at 3300 cm-1, which corresponds to N-
H. 
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Figure 6-2: (a) FT-IR spectrum of the Nickel IDT surface after coating with MPA. (b) FT-
IR spectrum of the EDC+NHS activated Nickel IDT surface. 
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6.2 Validation of Nickel Electrochemical Properties for Immunoassay Applications 
In Figure 6-3, we observed a significant change in impedance for the CRP antigens 
concentrations, which was in the frequency range of 50 MHz and 4 GHz. Also the 
impedance measurements observed from various concentrations (25, 800 ng/ml) of BSA 
and (500 ng/ml) of PSA (control proteins) as non-specific proteins are shown in Figure 6-3. 
The non-specific proteins responses corresponded with the blank measurements while the 
significant responses were obtained with the target CRP suggesting that the sensor surface 
can be used as a potential alternative electrode material for biosensing applications. 
However, detailed principle and underlying mechanism still needed to be explored. 
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Figure 6-3: The change in normalized impedance values measured after incubating CRP 
antibody concentration (100 µg/ml) with series of antigen concentrations (0, 
50, 250, 400, 800 ng/ml (CRP), 25, 800 ng/ml (BSA), and 800 ng/ml (PSA)) 
versus frequency as shown in the legend. 
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6.2.1 Extraction of Polarizability, a Cole-Cole Model Parameter 
The developed detection model (Chapter 4) was verified by fitting the experimental 
data acquired from immunoanalysis using nickel surface. The spectral impedimetric 
responses are consistent with the specific antibody-antigen interaction-model deduced, 
using the Cole-Cole model parameters. 
Table 6-1: Variation of Cole-Cole polarizability parameter (m) with specific interactions 
(with CRP antibody-antigen) and non-specific interactions (with BSA and 
PSA). 
 
The variation in polarizability (m) which is the difference of the polarization constant 
before and after incubation of antigen onto antibody, owing to the specific antibody-
antigen interaction, is shown in Table 6-1. To comply with the theoretical concept, the 
polarizability after antigen-antibody interactions should increase. The variation upto 800 
ng/ml target antigen concentration was around ~0.30, (positive). The increase in 
polarization constant after incubation is due to the rotation and the increase in the length of 
protein molecule[163]. The polarizability constant remains unchanged (~ -0.09), when 
control proteins (25, 800 ng/ml BSA and 500 ng/ml PSA) were applied onto CRP antibody 
Concentration 
(ng/ml) 
 
Polarizability (m) 
before incubation 
 
Polarizability (m) 
after incubation   
Polarizability (m) 
Difference 
            50 0.4077 0.6995 0.2918 
            100 0.3018 0.6020 0.3002 
            250 0.3090 0.6794 0.3794 
            400 0.3249 0.6474 0.3125 
            800 0.3405 0.6861 0.3456 
            25 (BSA) 0.3787 0.3282 -0.0505 
            800 (BSA) 0.4010 0.3106 -0.0904 
            500 (PSA) 0.5753 0.4611 -0.1142 
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surface.  This infers that CRP antibodies do not have receptors for BSA and PSA control 
proteins. Further, by observing the increase in polarization constant, which was consistent 
with our previous results (Chapter 4 and Chapter 5) suggesting that nickel-based electrode 
can be a cost effective alternative to the conventional electrode material such as gold.  
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Chapter VII 
7. SUMMARY, CONCLUSION, AND SUGGESTIONS FOR FUTURE WORK 
In this thesis the development and implementation of a microfluidic system for 
immunosensing applications are described. Different materials, chemistries and 
methodologies were considered with the objective of constructing a label-free, affinity-
based immunosensing microfluidic chip in which a sequential chemical modification 
process occurs in a controlled fashion. A silicon master is fabricated by means of UV-
photolithography. The master is used as a mould to cast an elastomer containing actuating 
and channel structures. The elastomer is irreversibly bonded to a gold patterned glass 
substrate after having been functionalized in oxygen plasma. The device was then actuated 
for fluid transfers by creating a pressure difference between the inlet and outlet. The 
function of the fluidic system as a LOC is verified by testing with different protein 
markers. In addition to this, label-free approach is also implemented for quantifying 
protein-ssDNA aptamer complex formation in buffer and human serum.  
 
To date no specific protocol has been defined for integrating fluidic components with 
biosensor. Therefore, it is important to consider several key issues that this thesis is mainly 
focused. Before concluding this work, in the development and integration of biosensor 
with a microfluidic system, several critical points have to be discussed sequentially, for eg., 
(a) why semiconductor substrate materials were chosen for sensor platform, (b) label-free 
method, (c) IDT geometry, (d) linker chemistry, (e) electrochemical analysis and (f) the 
behavior of proteins after complex formations. Further extensive research is required to 
address these issues for potential application of LOC in medical diagnostics or other vital 
applications. 
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7.1 Importance of Substrate 
Almost all types of biological recognition molecules can be attached to a solid 
substrate through a very wide variety of attachment mechanisms ranging from physical 
adsorption to an array of covalent binding procedures [164]. This guarantees an enormous 
diversity in biosensor specificity. The manners of signal transduction are also just as 
widespread, offering a suitable detection mechanism for every application, be it optical, 
mass-sensitive or electrochemical. The type of transducer material offers yet another 
degree of freedom since many materials can be functionalized with molecules using the 
correct attachment chemistry. However, not all transducer materials are usable with every 
type of transduction mechanism. A fluorescence detection strategy [165], for instance, 
requires a substrate with an intrinsically low background such as glass, while the electrical 
properties of the material has less importance. For example, SPR-based biosensors [166], a 
glass-Au or glass-Ag platform is mandatory. In electrochemical impedance spectroscopy 
(EIS) and field effect transistor (FET)-based transduction [167], semiconductors and 
metals are the preferred substrate and transducer material, since their conductivity can be 
controlled and cheap production methods are available. Diamond has proven to be an 
attractive alternate substrate material [168]. It can be made electrically semiconducting and 
it is chemically inert in a wide range of solutions that can be modified, inferring the desired 
functionality for the covalent attachment of biomolecules. However, high production cost 
is a serious disadvantage associated with the use of diamond substrates [169]. In EIS 
approaches, the parasitic losses during the low frequency analysis should be minimized 
[92], coating/oxidizing the semiconductor surface with a thin layer of dielectric decrease 
the parasitic effects [170]. 
 
The work presented in this thesis focused on impedance-based measurements. 
Semiconductor materials such as glass, oxidized silicon are our primary choice of substrate 
materials.  
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7.2 Method of Transduction 
Choosing a specific transduction principle depends largely on the type and purpose 
of the experiment. Since we aimed at point-of-care (POC) applications, desirable assets of 
every experiment are speed, reliability and cost. Reaction speed can be attained by 
eliminating the need for target labeling and offering the possibility of monitoring the 
recognition reaction in real-time and/or before and after analyte addition. A frontline 
requirement for test reliability is the generation of a dense and stably attached molecular 
layer on top of the substrate. Finally, cost is largely reflected by the required equipment 
and this certainly influences the possible integration of the platform in a POC application. 
 
When focusing on a fast, label-free, and real-time detection scheme, this immediately 
eliminates any indirect optical transduction principle (colorimetric, chemiluminescent, and 
fluorescent) [171]. Moreover, the required instrumentation for fluorescent detection usually 
represents a vast investment [172]. Similarly, Amperometry [173], Potentiometry [174] 
and conductometry [175] usually require enzymatic labels generating electro-active species 
that amplify the response. The EIS, FET-based transduction, SPR and QCM are generally 
considered to be capable of real-time and label-free analyte detection. However, SPR [166] 
sets very clear restrictions for the type of transducer material to be used. In this approach, 
Au or Ag will need to be bio-functionalized. QCM [176] is temperature sensitive and 
cannot readily be miniaturized and modified into a simultaneous detection scheme for 
many analytes. Thus, in this work label-free EIS method was used for taking the 
electrochemical measurements.  
7.3 Detection modeling of IDTs 
The geometry of the IDT and the properties of the substrate on which IDT patterned 
greatly influence the parameters resonant frequency, frequency of operation etc. Since the 
IDT being used for capacitive-based impediometric detection of protein interactions, the 
wide (400 µm) ground shielding arms placed around the IDT structure (Figure 2-2) 
increases the capacitance range of frequency. This is because most protein-based 
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interactions involve transfer of charges [177] which change dielectric properties of the 
medium.  
7.4 Linker Chemistry 
We developed few protocols (Appendix A) on the basis of the transducing 
mechanism which constitute an efficient two-step reaction to covalently attach 
protein/aptamer to metal electrode as an improvement and a significant simplification of 
the procedure that was suggested by Wang et al [178]. In a first step, a short chained thiol 
in ethanolic solution (3-MPA) was attached to metal electrode surface where the sulfur 
atoms adsorb to the metal surface during 24 hr incubation. The resulting COOH modified 
metal surface was then ideally functionalized for the subsequent attachment of 
protein/aptamer. The cross-linker molecule EDC in presence of NHS joined the COOH-
group of the metal surface to the NH2-group of the protein into a peptide bond.  
 
Our approach yields a very versatile, robust and efficient technique to covalently 
bind functional proteins/aptamers to metal surfaces. Importantly, our EDC mediated 
strategy offers the following advantages. It is a simple and reproducible two-step procedure 
in which EDC is a zero-length cross linker. This means that the molecule will not be 
present in the eventual peptide bond between the protein and the thiol on the metal 
electrode surface. For this reason, the protein molecules will be closer to the surface which 
is beneficial for electronic detection of the specific binding. 
7.5 Electrochemical Analysis 
This thesis is based on frequency-based EIS platform where S11 parameters were 
measured by different stages (blank IDT, after SAM formation, with the protein/aptamer, 
after capturing of various concentrations of target on the immobilized IDTs). All 
measurements were performed in triplicates for the meaningful error analysis. The 
parameters were exported to Matlab and capacitive components were extracted for the 
analysis. The changes in capacitance or dielectric properties were compared (signal from 
blank, control and after target capturing) in the analysis. 
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With the characterization of fabricated IDT structures (Appendix C) it is observed 
that each IDT shows a variation of ~0.01-0.1 pF from the base DC capacitance of 2 pF. 
Thus, to eliminate such small variations in result, each extracted value from an IDT is 
normalized with its own previous measurement result.   
7.6 Protein complex formation and Its Influence 
The specific antibody-antigen interaction stimulate polarization on the sensor surface 
and polarization is invariably linked to the dielectric properties[177]. Hence, the 
impedance parameters vary with the protein complex formations. The level of protein 
hybridization can be influenced by size/nature of proteins and medium. 
7.6.1 Size-dependent Variations of complex formation 
Basing on the number of amino acid side chains attached to the monomer unit, the 
size of the protein marker is defined [179],for instance, IL6 (each monomer consists of 184 
amino acids) [103]. When the protein markers bind to their respective target they 
hybridize. The target antigens interact and bind to the specific antibody by which they 
achieve certain active and vibrating three dimensional (3-D) conformations [99-100] which 
consist of the formation of folds, twisting or compression of protein polypeptide chains. 
The vibrations of protein molecule lead to the displacement of electric charges on their 
surface and thus, a particular frequency can interact with these vibrations [180]. Moreover, 
there is evidence that proteins have certain conducting or semi-conducting properties, a 
charge moving through the protein backbone and passing different energy stages caused by 
different amino acid side groups can produce sufficient conditions for a specific 
electromagnetic radiation or absorption. Hence, the frequency of conformational vibration 
strongly depends on size of 3-D structure which varies from one protein to another. Thus, 
the response of IDTs treated with hEGFR protein is consistent in the range of 230-280 
MHz (Figure 4-3) whereas IDTs immobilized with IL6 are consistent in the range of 140 to 
200 MHz (Figure 4-4). 
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7.6.2 Effect of Medium on Protein Complex 
The dielectric responses for target spiked in serum immobilized with aptamer 
showed considerably higher changes when compared the same concentrations of target in 
buffer (Figure 5-2 and Figure 5-3). This was probably because of several factors that can 
affect the behavior of dielectric responses. For example, the charged constituents of serum 
contribute the net charge transfer after target binding. 
7.7 Summary of Achievements 
Within the primary scope of this thesis for the development of LOC for multiple 
disease marker detection, different experimental works was performed. Further, the 
developed label-free technology was used to realize a Nampt aptasensor and verified the 
use of nickel as a transducing electrode. To show the improvement of the work achieved in 
this research a comparison of experimental results was carried with the existing literature.  
7.7.1 Microfluidic System 
Various experimental models [73, 119, 181] of instrument-free on-chip actuating 
fluidic systems have been studied for the development of the two stacked PDMS-based 
fluid transferring system. Every model has a set of limitations such as cost and complexity 
in fabrication, need for skillful operation and application which hinder the future 
developments. However, the developed fluidic system is manufactured using a single 
mylar mask with a simple two step fabrication protocol. A single actuator is designed to 
perform both sprouting and sucking of the liquid samples and an air vent was used to 
control the fluid flow (forward/backward) by releasing the back-pressure of the actuator. In 
this work, we achieved a controllable flow rate of 300 nl/sec with hand-operation which is 
lower than 15.4 µl/sec [72]. Very low sample volume consumption (~ 60 µl) is an added 
advantage. Moreover, the flexibility of the design to stop the liquid flow at any instant of 
time can be used for incubation purposes in immunosensing LOC applications which is not 
available with previous works. Table 7-1 summarizes the performance of the developed 
immunosensing LOC. 
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Table 7-1: Performance of the developed immunosensing LOC. 
 
LOC features Advantageous(+)/ 
Disadvantageous (-) 
Comments 
 
Fabrication 
complexity 
LOC is a two stacked 
PDMS layered 
device bonded onto a 
pre-patterned glass 
substrate. 
 
++++ 
Very easy to fabricate 
and achieve the 
bonding alignment as 
there are only three 
stacked layers. 
 
 
Fabrication 
expenses 
With a single mask, 
master mould can be 
patterned and it can 
be used for multiple 
manufacturing 
processes. 
 
 
++++ 
 
Each fabricated 
microfluidic system is  
< 5 USD. 
 
Fluid 
transfer 
By the application of 
hydraulic load 
peristaltic action was 
generated. 
 
++++ 
 
On-chip actuation 
mechanism. 
 
Fluid 
control 
Without any need of 
external instruments 
the fluid flow is 
controlled. 
 
++++ 
 
A cover layer on the air 
vent is used as fluid 
control unit. 
 
 
Multiple 
biomarker 
detection 
With two cognitive 
controls, a   
maximum of six 
markers can be 
quantified using a 
single LOC. 
 
 
++++ 
 
In this work LOC is 
designed to detect two 
different types of 
disease markers (EGFR 
and IL-6). 
 
 
Sample 
volume 
 
For testing, 20 µl 
volume of serum 
sample is required. 
 
 
++++ 
The volume of required 
sample is very low 
when compared to any 
available label-free 
immunosensing LOC 
[72, 119]. 
 
 
Analysis 
time 
 
The protocol 
developed in this 
work need 1 hr. 
 
 
----- 
The surface 
functionalization 
protocols can be 
modified and analysis 
time can be minimized. 
 
 
Portability 
LOC is designed to 
fit on a microglass 
slide area of  
7.5X5 cm2. 
 
++++ 
In the design, on-chip 
actuator is placed 
separately which 
occupies larger area.  
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7.7.2 Biomarker Detection 
Different investigators utilize different types of detection methodologies, even to 
detect the same target [182]. Thus, being a label-free in approach for the detection of 
biomarkers would be more advantageous and appropriate to compare our results with other 
label-free techniques (such as QCM, SPR, and CV). 
Table 7-2: Examples showing detection range of IL-6 markers using different techniques. 
Method 
Type of Medium Sensitivity and Detected range Outcome of this 
work 
SPR Cell culture 0.78-12.5 ng/ml [183]  
0.1-5 ng/ml in 
serum 
CV Buffer 5 E-10 to 5E-13 mM[184] 
IDT Buffer 25 pg/ml to 25 ng/ml [185] 
 
With the label-free methodology, there exists limited work performed for the 
quantification of interleukin-6 marker (Table 7-2). Moreover, the amount of anti-IL6 used 
in the experimentation was not clearly mentioned in the literature [183-184]. From our 
laboratory we reported a detection limit of 25 pg/ml in buffer [185]. In this work, for 30 
µg/ml of anti-IL6 on a specified area, we achieved a detection limit of 100pg/ml in serum, 
and the use of serum is an added advantage for the detection in real patient samples. This 
fair comparison provides that our label-free approach using IDT platform is more 
functional with complex/biological background (in serum) while other methods use antigen 
in buffer. 
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Table 7-3: Examples showing detection range of CRP markers using different label-free 
techniques. 
Method 
Type of 
Medium 
Sensitivity and Detected range Outcome of 
this work 
QCM Buffer 0.13-25.016 ng/ml [186]  
50-250 ng/ml 
(buffer) 
SPR Buffer 2-5 µg/ml [187] 
Piezoresistive 
cantilever 
Buffer 10 ng/ml-1µg/ml [188] 
 
The quantification of CRP protein was performed on nickel platform, where CRP 
was used as a model analyte with an aim to investigate alternate transducing electrode for 
biosensing applications. We observed a dynamic detection range of 50-250 ng/ml target for 
a given anti-CRP concentration (100 µg/ml). This range falls within the concentration 
levels of CRP-antigen in a cardiovascular disease risk conditions [189]. Table 7-3 shows 
the comparison of the CRP detection range by other methods. One of the methods showing 
lowest detection range has been reported by Kim et al [186] quantifying CRP in buffer 
with a detection range of 0.13 to 25.016 ng/ml using 2 mg/ml concentration of anti-CRP 
antibodies. The concentration of antibody used by other researchers as indicated above was 
high when compared with our current approach. There exists a little information available 
for the detection of other protein markers such as, hEGFR and Nampt using label-free 
techniques. However, with ELISA techniques, a detection limit of 7-162 fmol/ml (21.50 
fmol/ml ~ 850 ng/ml) in serum was reported for hEGFR [190]. We have obtained a 
detection limit of 0.1 ng/ml for hEGFR and 1 ng/ml of Nampt using aptasensor in serum. 
Although the detection limit was not as sensitive as ELISA, however, this label-free 
method is rapid, less expensive and easy to use method for potential diagnostic 
applications. 
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7.8 Conclusion 
 
In conclusion, the ability to quantify the level of multiple disease markers from 
serum is critical to ensure improved diagnosis and patient management in the early stages 
of disease. Microfluidic LOC technologies have shown potential in the development of 
point-of-care technologies for the rapid quantification of disease markers in serum [182]. 
Therefore, the aim of this thesis work was to design and fabricate a microfluidic 
system/device that could be integrated with an immunosensing platform for multiple 
disease markers detection. In particular, the fluidic device is designed to operate without 
any need for additional instrumentation to drive the working fluids from which the disease 
markers to be detected.  
 
In this thesis, we have developed a prototype of an on-chip actuated microfluidic 
system. The system is designed to transfer fluid with the application of hydraulic load on 
the single integrated actuator for immunosensing applications. Label-free affinity-based 
immunosensing methodology was implemented to verify the use of fluidic system as a lab-
on-a-chip (LOC) with integrated biosensing platform. We focused on multi-target detection 
using this LOC. With dose dependent analysis, we achieved a detection limit of 0.1 ng/ml 
for hEGFR and 0.1 ng/ml IL-6 concentrations in serum using specific antibodies. An array 
setup with multiple markers is proposed that it offers at least one negative control to 
analysis cycle can be executed for detection of target proteins. The developed microfluidics 
system can be hand-actuated and easily integrated to a platform where there is no 
availability of external fluid driving mechanisms or power sources. This new prototype 
enabled both consistent capacitance reading and also real-time detection to be performed in 
complex serum. The realized fluidic system with integrated biosensor platform will be 
extended from a proof-of-principle into a clinical setting. We wish to extend our novel on-
chip actuating mechanism to other fields such as delivery of sensitive samples, for field-
portable and point-of-care (POC) applications. 
 
The work presented in this thesis laid the groundwork for the development of a 
prototype of a LOC for real-time and label-free impedimetric immunosensing applications. 
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Although the target biomarkers used in this study are of intrinsically different nature and 
their respective effects on the impedance introduced us to the fundamental events that 
occur during antigen/target recognition. This will be developed further into a prototype of 
an immunosensor with the ability to discriminate between two different targets/antigens 
comparable in charge distribution. Eventually, the sensitivity and specificity of the sensor 
will be challenged with patient whole serum. In addition, no external equipment is needed 
to drive the fluid which provides neat flow of bio-fluids/wash buffers and can maintain a 
stable environment on the IDT surface. This rather innovating approach, combining low 
cost, system stability and reliability, holds promise to grow into a valuable complementary 
technique for the widely applied endpoint microarrays. 
 
In addition, theoretical Cole-Cole model parameters were extracted that 
demonstrated the impedimetric properties of the surface upon the protein complex 
formation. The model also implies that dielectric properties dominated the fringing effects 
between the finger electrodes. Further, we have demonstrated that the label-free affinity-
based methodology can be used in realizing aptasensors for the detection of protein 
molecules where the classical use of antibodies were replaced by specific aptamers. 
7.9 Future prospects 
Electronic signal readout from the IDTs, for instance, the width and pitch of the 
electrical contact arrays to transfer the bio-analytical signal introduces signal loss and 
increase the overall size of the LOC system. This can be surpassed with new compact 
designs of assemblies/fixtures. A major limitation comes from the less stability of 
integrated biological molecule for sensing specific target during the development of a high-
throughput miniaturized LOC-based immunosensor system. First of all, any attempt to 
regenerate the active, antibody-modified sensor surface will often result in the inactivation 
of these bio-recognition molecules (antibodies). Secondly, the production of monoclonal 
antibodies is a very complicated and tedious procedure, expensive and difficult to obtain 
for few target biomarkers. Therefore, alternative biological sensing elements, such as 
chemically synthetic aptamers are to be explored to replace classical use of antibodies. 
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This thesis has provided a suitable biosensing platform with sufficient flexibility to 
implement alternative setups. Thanks to our interdisciplinary expertise, these new 
pathways towards biosensor development allow the establishment of new and exciting 
research initiatives. All together, the groundwork was laid for obtaining a reliable and 
sensitive impedimetric sensing scheme for proteins using antibodies and aptamers. 
However, many demands are yet to be met and several factors needed to be taken into 
consideration in order to use LOC applicable in routine clinical diagnostics. A prerequisite 
for both types of sensors is their compatibility with ‘real-life’ samples for use in routine 
diagnostics and research. The LOC-based impedimetric biosensor needs to be expanded 
from a proof-of-principle into a sensor that retains its sensitivity and specificity when 
challenged with patients’ samples for analysis. Though we tested for a few proteins in 
serum, the impedimetric immunosensor must still remain functionally active in 
physiologically relevant ranges in whole serum. Both the immunosensing LOC and the 
hand-held readout not only need to be miniaturized for portability and easy handling, but 
also to decrease analysis time into the minute-scale. For the immunosensor, this 
miniaturization will also ensure a point-of-care application. In order to comply with all of 
these demands, the first task at hand is the optimization of crucial parameters. These 
include surface functionalization methods, density of probes, target concentration, novel 
and miniaturized sensor designs for electro-chemical transducing and reliable fabrication 
schemes in order to obtain a specific, sensitive and reliable impedance response at chosen 
frequency. These issues will form the subjects of subsequent research projects and 
challenges that lay before us. 
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APPENDIX 
A. Assay Design And Optimization 
 
Buffers and solutions 
In the following section, a summary is given entailing the source of purchased solutions 
and the compositions of buffers that are prepared and being used throughout the thesis. 
 
Basic:  
1.2 M NaOH 
74% NH4OH 
Acidic:  
1.2 M HCl 
90% H2SO4 
100% HNO3 
Salts:  
1 M NaCl 
1 M KCl 
Conjugation buffer 
1X PBS, containing: 0.05% Tween 20 
10 X Phosphate buffer saline (PBS), pH 7.2 
1.29 M NaCl 
0.05 M Na2HPO4.2H2O 
0.015 M KH2PO4 
 
Purchased materials/chemicals 
GOx 50KU (168,800 units/g), phosphate buffer saline (PBS, pH=7.4), potassium iodide, 
Iodine, acetone, Isopropyl alcohol, 3 mercaptopropionic acid (3 MPA), 10 
mercaptoundeconic acid (10 MUDA), 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide(EDC), N-hydroxysuccinimide (NHS) are purchased from Sigma-Aldrich. Β-
D-glucose, disodium hydrogen phosphate, sodium dihydrogen phosphate, potassium 
ferrocyanide, potassium chloride, hydro fluoric acid, nitric acid, sodium acetate were all 
acquired from Merck, Darmstadt, Germany. All solutions used in the experiments were 
prepared with deionized water (18.2 MΩ/cm, Millipore).  
Wafers/Substrates and electrode materials 
During the course of this thesis, silicon (Si), silicon dioxide (SiO2) 1 µm thick grown on 
Silicon wafers and Micro glass slides as substrates are utilized as base units for sensor 
surfaces. The metals like gold, titanium (adhesion promoter, to the gold), and nickel are 
used as electrode materials.  
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Wafer cleaning procedure 
Pre-fabrication cleaning is performed on all wafers and substrates used in experiments. 
RCA-1 Cleaning 
This process of cleaning is utilized for removal of organic contaminants. The application 
was performed with 1:1:5 solution of NH4OH (ammonium hydroxide) + H2O2 (hydrogen 
peroxide) + H2O (water) at 75 or 80 °C typically for 10 minutes. The treatment results in 
the formation of a thin silicon dioxide layer (about 10 Angstrom) on the silicon surface, 
along with a certain degree of metallic contamination (notably Iron) that shall be removed 
in subsequent step (RCA-2). This is followed by transferring the wafers into a DI 
water bath. 
RCA-2 cleaning 
In removal of the metallic contaminants deposited during RCA-1 clean, this process is 
performed with 1:1:6 solution of HCl + H2O2 + H2O at 75 or 80 °C. The treatment 
effectively removes the remaining traces of metallic (ionic) contaminants. This is followed 
by transferring the wafers into a DI water bath. 
Piranha cleaning 
This process (also known as piranha etch) is applied to remove organic impurities from the 
substrate surface. This is performed with 3:1 solution of H2SO4 (sulfuric acid) and H2O2 
(hydrogen peroxide) at 1300 C for 15 minutes. This mixture is a strong oxidizer, it will 
remove most organic matter, and it will also hydroxylate most surfaces (add OH groups), 
making them extremely hydrophilic (water compatible). 
Plasma cleaning 
The use of plasma is an effective way to clean wafers/substrates without using hazardous 
solvents. Plasma is an ionized gas capable of conducting electricity and absorbing energy 
from an electrical supply. Manmade plasma is generally created in a low-pressure 
environment. When a gas absorbs electrical energy, its temperature increases causing the 
ions to vibrate faster and “scrub” a surface. We used equipment, DSE ICP DRIE at 50 W 
for 30 seconds to 1 minute with oxygen and argon as plasma gases. 
 
Optimization of linker molecule chemistry 
Adsorption, entrapment, and covalent attachment are the leading techniques employed for 
the immobilization of biomolecules onto solid metal supports. Adsorption of biomolecules 
is simple and mild. Entrapment of biomolecules in a polymer or within a membrane sealing 
appears to be straightforward, but in fact, there are technical snags when the analyte is 
large, movement through the polymer or membrane may be restricted. Thus throughout 
this thesis covalent attachment method was preferred over others for biomolecule binding.  
In this section a series of procedures/protocols involving the use of SAMs are described 
which exploit the covalent functionalization/modification of gold with organo-sulfur 
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compounds (3 MPA, MUDA) and/or silicon/silicon dioxide/glass with silanes (MPTS, 
APTS). 
Silanization 
During earlier stage of thesis work, silanization technique was employed for 
functionalization of active sensor surface. There are numerous ways to silanize surface and 
covalently attach biomolecules. This section concentrates on the methodology used in 
silanizing, the pre-fabricated IDT structures on glass/SiO2-Si substrates. The critical part of 
covalently modification is the preparation of the solid support to generate reactive 
hydroxyls. Thus surface cleaning was performed as explained in section 3.1.2.1.  
Protocol 1 
(3-glycidoxypropyl)-trimethoxysilane (GPTS) was occasionally used for protein 
attachment. The epoxide group must be hydrolyzed and modified for reaction with the 
biomolecule directly or with cross linkers. Once the epoxide group is opened, additional 
modifications can be performed to get the desired reactive group. 
Immerse the wafer/substrate with pre fabricated IDTs in 2-10 % GPTS solution in 95% 
EtOH in ddH20 for 1 h at room temperature. 
Remove the silanized wafer/substrate from the solution and dry at 50 0C for 6 h. 
Immobilize proteins onto the silanized IDTs and incubate for 2 h at RT. 
Rinse the protein coated IDTs with PBS and can be stored or used for antigen incubation.      
Protocol 2 
Octadecyltriethoxysilane (ODTS) was also employed for covalently linking the 
biomolecules.  
Immerse the wafer/substrate with pre fabricated IDTs in 2 % ODTS solution in Toulene 
and incubate for 24 h at RT. 
Remove the silanized wafer/substrate from the solution and rinse the wafer/substrate with 
Toulene. 
After nitrogen drying at RT for 5 mins, the silanized IDTs are protonated by EDC-NHS 
coupling. 
After 4 h incubation at RT, protein immobilization is performed on the IDTs.  
The modified IDTs can be stored or used for antigen incubation.   
 
Alkane thiolization 
During the course of thesis, the structural understanding of thiol compounds on metals was 
developed. In this section, design methods to reduce the nonspecific adsorption (NSA) of 
alkanethiol SAMs, which are popular linker molecules in biosensor applications. Different 
design parameters were studied for two different chain-length SAMs (n = 2 and 10). 
However, in the interest of this work the following protocol is developed and utilized. 
Protocol 3  
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The following 10 mM, MPA,/MUDA, and 1 mM, cysteamine solutions were employed for 
alkanethiolating the patterned metal IDTs. Basing on the need for different reactive group 
different alkanethiol is utilized.  
The fabricated IDT structures are cleaned using plasma as explained in section 3..  
1-10 mM solution of appropriate thiol is prepared in EtOH. The wafers/substrates were 
incubated in the solution for 24 h at RT.  
After cleaning the wafers with ddH2O the thiol SAMs are activated/protonated using EDC-
NHS coupling solutions. 
On activated IDTs the proteins were immobilized and incubated for 2 h at RT. 
The modified IDTs can be stored or used for antigen incubation and measurement.    
B. Matlab code for Cole-Cole model parameter extraction 
 
clear all; 
X=XLSREAD(‘Filename’); 
x1=X(:,1); 
x2=X(:,2); 
x3=X(:,3); 
NN=size(x1); 
N=size(x1); 
p=ones(1,NN);%for field data 
q=ones(1,NN);%for theoretically estimated data 
Dt=rand(1,N);%white noise, this is for testing robustness 
for n=1:NN  %calculate field data 
    p(n)=x2(n).*(cos(x3(n)./1000)+i.*sin(x3(n)./1000)); 
end;    
 
%Intermediate variable buffers 
Mu=ones(1,N-1); %mu 
Le=ones(1,N-1); %lambda 
Ph=ones(1,N-1); %phi 
Ps=ones(1,N-1); %psi 
A=ones(1,N-1);  %for A_k 
C=ones(1,N-1);  %for C_k 
D=ones(1,N-1);  %for D_k 
 
%Parameters 
CC0=-1; %c 
PP0=-1; %rho_0 
MM0=0; %m 
TT0=0; %tau 
 
%Set searching interval for Golden Section Algorithm 
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%GN=20; %Number of sub-intervals 
GN=20; 
g0=1;%the optimal interval 
Smin=0;%smallest S 
CM=0; ECMIN=0; EV=ones(1,2); EP=ones(1,2); EX=ones(1,2); EM=ones(1,2);%For 
swap indexes 
COUNTMAX=100; %limit of iteration 
 
for gi=1:GN 
gd=0.998/GN; 
   CH=0.001+gi*gd; 
   CL=CH-gd; 
 
    %For swap indexes 
   CM=0; ECMIN=0;  
 
    DC=CH-CL; 
    %Calculate intermediate variables 
    for k=1:N-1 
        Mu(k)=real(1/(p(k+1)-p(k))); Le(k)=imag(1/(p(k+1)-p(k))); 
Ph(k)=real(p(k+1)/(p(k+1)-p(k))); Ps(k)=imag(p(k+1)/(p(k+1)-p(k))); 
    end;       
 
    COUNT=0; %Count the number for golden iteration 
 
    ID=1;%Index if the new testing point: ID=1 means new testing point is at  
    %lower position (0.382), ID=2 means new testing point is at higher position (0.618) 
 
    %set first two testiong points 
    C1=CL+(CH-CL)*(1-0.618);  
    C2=CL+(CH-CL)*0.618; 
 
%For golden section algorithm       
while DC>0.001&COUNT<COUNTMAX 
    if COUNT==0 
        ID=1; 
elseif COUNT==1 
        ID=2; 
       end;    
    if ID==1 
        c=C1; 
       else 
       c=C2; 
       end; 
 
       %For calculating A,C,D; 
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    SN=sin(c*pi/2);  
       CS=cos(c*pi/2); 
 
       for k=1:N-1 
         %     w1=x1(k); w2=x1(k+1); D(k)=w2^c/(w1^c-w2^c); 
           w1=x1(k)*2*pi; w2=x1(k+1)*2*pi; D(k)=w2^c/(w1^c-w2^c); 
            A(k)=CS*w1^c*D(k); C(k)=SN*w1^c*D(k); 
       end; 
 
        %For calculating P 
        S1=0; S2=0; 
    for k=1:N-1 
         w1=x1(k)*2*pi; w2=x1(k+1)*2*pi; 
        P1=(A(k)*Mu(k)+C(k)*Le(k)); P2=(w1^c*D(k))^2; 
            S1=S1+P1; S2=S2+P2; 
    end; 
        P=S1/S2; 
 
        %For calculating H 
        S1=0; S2=0; 
    for k=1:N-1 
         w1=x1(k)*2*pi; w2=x1(k+1)*2*pi; 
        H1=A(k)*(Ph(k)+D(k))+C(k)*Ps(k); H2=(w1^c*D(k))^2; 
        S1=S1+H1; S2=S2+H2; 
        end; 
        H=S1/S2; 
 
    %Construct M, L 
        M=ones(2*N-2,1); L=ones(2*N-2,1); 
        for k=1:N-1 
        M(2*k-1)=A(k)*P-Mu(k); M(2*k)=C(k)*P-Le(k); 
            L(2*k-1)=A(k)*H-Ph(k)-D(k); L(2*k)=C(k)*H-Ps(k); 
        end; 
 
    %Estimate parameters for given c 
        %Assume p0 is real 
    EP(ID)=inv(M'*M)*M'*L;% estimate rho_0 
       p0t=EP(ID);  
 
    EX(ID)=P*p0t-H;% estimate tau^c 
Xt=EX(ID); CS=cos(c*pi/2); SN=sin(c*pi/2); 
    S1=0; S2=0; 
    for k=1:N 
         O=(CS+i*SN)*(x1(k)*2*pi)^c*Xt; Q=abs(O/(1+O)); P=abs(1-p(k)/p0t); 
        S1=S1+Q*P; S2=S2+Q*Q; 
    end; 
91 
 
    EM(ID)=S1/S2; %estimate m 
mt=EM(ID); 
 
    %Calculate estimated value rho(k) for given c 
        for n=1:N 
         %      q(n)=p0t*(1-mt*(1-1/(1+(CS+i*SN)*(x1(n))^c*Xt))); 
            q(n)=p0t*(1-mt*(1-1/(1+(CS+i*SN)*(x1(n)*2*pi)^c*Xt))); 
    end; 
 
 
    %Get best interval    
    if gi==1 
      g0=1; 
Smin=S; 
      %Get parameter c 
cr=CC0; 
        %Get parameter rho_0 
        p0r=PP0; 
        %Get parameter tau 
tr=0; 
        if XX0>0; 
tr=XX0^(1/cr); 
        end;    
        %Get parameter m; 
mr=MM0; 
   else 
      if S<Smin 
         g0=gi; 
Smin=S; 
        %Get parameter c 
cr=CC0; 
            %Get parameter rho_0 
            p0r=PP0; 
            %Get parameter tau 
tr=0; 
            if XX0>0; 
tr=XX0^(1/cr); 
            end;    
            %Get parameter m; 
mr=MM0; 
      end; 
   end;    
end; 
%For overall error 
CS=cos(cr*pi/2); SN=sin(cr*pi/2);    
for n=1:NN 
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   % q(n)=p0r*(1-mr*(1-1/(1+(CS+i*SN)*(w(n)*tr)^cr))); 
   q(n)=p0r*(1-mr*(1-1/(1+(CS+i*SN)*(x1(n)*2*pi*tr)^cr))); 
end; 
S=0; 
for n=1:NN 
    S=S+(real(p(n))-real(q(n)))^2+(imag(p(n))-imag(q(n)))^2; 
 end;    
%Show result  
%S %overall error 
%COUNT %number of iterations 
p0r % rho_0 
tr  % tau 
mt % m 
C. Structural Characterization of Fabricated IDT on Glass 
 
The reproducibility of IDT fabrication process was investigated by measuring the dry 
capacitances of the electrodes. The variation between the consequent measurements of the 
same IDE (Figure D-1(a)) and the measurement differences between different IDEs (Figure 
D-1(b)) were minimal, showing that the optimised fabrication process produces good 
quality IDEs and the custom made PCB provides good connection between the IDEs and 
the LCR meter. Hence the developed system is suitable for use as a prototype biosensor. 
 
Figure D-1:(a) Each IDE on a glass slide was measured three times and the averages of the 
readings were plotted in the graph. (b) Capacitance measurements of IDEs in 
three different glass slides were compared. 
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